Development of Molecular Contrast-enhanced Imaging for Optical Coherence Tomography by Kim, Wihan
DEVELOPMENT OF MOLECULAR CONTRAST-ENHANCED IMAGING FOR 
OPTICAL COHERENCE TOMOGRAPHY  
A Dissertation 
by 
WIHAN KIM 
Submitted to the Office of Graduate and Professional Studies of 
Texas A&M University 
in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
Chair of Committee,  Brian E. Applegate 
Co-Chair of Committee,   Javier A. Jo 
Committee Members,       Alvin T. Yeh 
Yong-joe Kim 
Head of Department, Anthony Guiseppi-Elie 
May 2017 
Major Subject: Biomedical Engineering 
Copyright 2017 Wihan Kim 
 ii 
 
ABSTRACT 
Biological imaging techniques that are able to detect a contrast-enhanced signal 
from the target molecules have been widely applied to various techniques in the imaging 
field. The complex biological environment provides numerous and more efficient 
pathways along which the chromophores (light absorber) may release its energy. This 
energy can provide not only morphological information, but also specific molecular 
information such as a biochemical map of a sample. All diseases correlate with both 
morphological and biochemical changes.  
Optical coherence tomography (OCT) system is one of the biological imaging 
techniques.  OCT has widely been applied to many medical/clinical fields, giving benefit 
from a penetration depth of a few millimeters while maintaining a spatial resolution on 
the order of a micron. Unfortunately, OCT lacks the straightforward functional 
molecular imaging extensions available for other technologies, e.g. confocal 
fluorescence microscopy and fluorescence diffuse optical tomography. This is largely 
because incoherent processes such as fluorescence emission and Raman scattering are 
not readily detectable with low coherence interferometry that is the central technique 
that underlies all OCT systems. Despite a drawback of molecular imaging with OCT, it 
is highly desirable to measure not only morphological, but also molecular information 
from either endogenous or exogenous molecules. 
In order to overcome the limitation of molecular contrast imaging for OCT, our 
group has been researched the hybrid OCT imaging technique and a new exogenous 
contrast agent. Our contrast-enhanced imaging technique integrates OCT with a well-
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researched and well-established technique: two-colored pump-probe absorption 
spectroscopy. Our novel imaging technique is called Pump-Probe OCT (PPOCT). Based 
upon current successful results, molecular imaging with OCT potentially gives us the 
ability to identify pathologies. In order to expand the capacity of PPOCT, this 
dissertation focuses on development of molecular contrast-enhanced imaging for optical 
coherence tomography (OCT). 
In the first phase of the research, we developed and optimized for sensitivity a 
two-color ground state recovery Pump-Probe Optical Coherence Tomography 
(gsrPPOCT) system and signal algorithm to measure the contrast-enhanced signal of 
endogenous and exogenous contrast agents such as Hemoglobin (Hb) and Methylene 
blue (MB) from in vivo samples. Depending on the absorption peak of a target molecule, 
the pump light sources for PPOCT used 532nm Q-switched laser or 663nm diode laser. 
Based on different experimental application, Ti:sapp or SLD of 830nm center 
wavelength were utilized. The PPCOT system was firstly used to image Hb of in vivo 
vasulature in a Xenopus laevis as the endogenous contrast agent and a larval stage 
zebrafish using MB as the exogenous contrast agent via transient changes in light 
absorption. Their morphological in addition to molecular specific information from a 
live animal was described. The incorporation of a pump laser in an otherwise typical 
spectrometer based OCT system is sufficient to enable molecular imaging with PPOCT. 
In the second phase of this research, based on endoscopic molecular contrast-
enhanced applications for OCT, we invented an ultra-wideband lensless fiber optic 
rotary joint based on co-aligning two optical fibers has excellent performance (~0.38 dB 
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insertion loss). The developed rotary joint can cover a wavelength range of at least 355-
1360 nm with single mode, multimode, and double clad fibers with rotational velocities 
up to 8800 rpm (146 Hz). 
In the third phase of this research, we developed and manufactured a 
microencapsulated methylene blue (MB) contrast agent for PPOCT. The poly lactic-co-
glycolic acid (PLGA) microspheres loaded with MB offer several advantages over bare 
MB. The microsphere encapsulation improves the PPOCT signal both by enhancing the 
scattering and preventing the reduction of MB to leucomethylene blue. The surface of 
the microsphere can readily be functionalized to enable active targeting of the contrast 
agent without modifying the excited state dynamics of MB that enable PPOCT imaging. 
Both MB and PLGA are used clinically. PLGA is FDA approved and used in drug 
delivery and tissue engineering applications. 2.5 µm diameter microspheres were 
synthesized with an inner core containing 0.01% (w/v) aqueous MB. As an initial 
demonstration the MB microspheres were imaged in a 100 µm diameter capillary tube 
submerged in a 1% intralipid emulsion. By varying the oxygen concentration both 0% 
and 21%, we observed he lifetime of excited triple state using time-resolved Pump-Probe 
spectroscopy and also the relative phase shift between the pump and probe is a reliable 
indicator of the oxygen concentration. Furthermore, these results are in good agreement 
with our theoretical predictions. This development opens up the possibility of using MB 
for 3-D oxygen sensing with PPOCT. 
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1. INTRODUCTION* 
 
1.1 Background 
Optical coherence tomography (OCT) is a rapidly developing imaging technology 
that is gaining clinical acceptance in cardiology and is widely used in clinical 
ophthalmology. Beyond what is currently FDA approved, OCT is being investigated as a 
tool for a variety of applications including; diagnosing cancer (e.g. esophageal [2, 3], 
bladder [4], and oral [5, 6] cancers), diagnosing skin diseases [7], monitoring 
wound/burn healing [8, 9], and assessing tumor margins [10, 11]. Similarly, OCT is 
playing a growing role in support of research into the development and progression of 
human disease as well as the development of organ systems in animal models [12].  
OCT can provide tomographic images with micron scale resolution and rapid 
imaging speeds. Typically, the imaging depth in highly scattering tissues is 1-2 mm, but 
it can be much higher in weakly scattering tissues such as the eye. A unique aspect of 
OCT among other optical imaging technologies is that the axial resolution is 
independent of the lateral resolution. This feature is particularly important for imaging in 
the eye where the optics of the eye determine the lateral resolution. Likewise, imaging 
the coronary arteries requires a long depth of focus (lower lateral resolution) due to the 
fact that the relative position of the intravascular catheter endoscope to the artery lumen 
                                                
*  Parts of this section were taken from [1] P Mattison, Scott, Wihan Kim, Jesung Park, and Brian E 
Applegate. "Molecular Imaging in Optical Coherence Tomography." Current molecular imaging 3, no. 2 
(2014): 88-105. 
 2 
 
is not controlled. While the lateral resolution may suffer in both cases, the axial 
resolution can be maintained at the obvious expense of an asymmetric voxel. Typical 
lateral resolutions range from 10-40µm, whereas the axial resolution is inversely 
proportional to the frequency bandwidth of the light source and typically ranges from 3-
15µm. 
Cross-sectional and volumetric images are captured by scanning the illumination 
in x and y while collecting line images in z. Hence, the line-rate fundamentally limits the 
image acquisition speed. Typical line rates for OCT range from 50-200 kHz and are 
sufficient to mitigate many of the issues other imaging technologies have with motion 
artifact, even the fast saccades of the eye. Line rates in excess of 1 MHz [13, 14] have 
been demonstrated; opening up the possibility of measuring fast dynamical processes. 
OCT fills a niche between the higher-resolution optical imaging technologies such as 
confocal reflectance microscopy and the lower-resolution technologies such as diffuse 
optical tomography. It offers high-speed, high-resolution tissue level imaging of 
morphology that cannot readily be generated in any other way. Unfortunately, OCT 
lacks the straightforward functional molecular imaging extensions available for these 
other technologies, e.g. confocal fluorescence microscopy and fluorescence diffuse 
optical tomography. This is largely due to the fact that incoherent processes such as 
fluorescence emission and Raman scattering are not readily detectable with the 
technique that underlies all OCT systems, low coherence interferometry. Fundamentally, 
OCT images are derived from measuring spatial variations in the intensity of 
backscattered near infrared light. These spatial variations arise from small changes in the 
 3 
 
tissue refractive index. Changes in the refractive index unfortunately correlate poorly 
with specific biomolecular species. These facts have made it difficult to develop 
functional extensions of OCT that would enable molecular imaging. Still, molecular 
imaging with OCT through either endogenous or exogenous contrast agents is highly 
desirable, as it would enable functional biomolecular imaging in addition to the 
morphological imaging available through standard OCT. 
  Given the growing penetration of OCT into clinical practice, robust molecular 
imaging extensions could have long term clinical impact. To that end, a significant effort 
has been brought to bear on the development of techniques to enable molecular imaging 
with OCT. A variety of approaches have been and are continuing to be developed. There 
is also a growing body of work dedicated to combining OCT with other optical imaging 
technologies that can already garner molecular information. 
The primary examples of molecular imaging with OCT are photothermal OCT [15, 
16], magnetomotive OCT [17, 18], and spectroscopic OCT [19, 20].  Photothermal OCT 
(PTOCT) provides absorption based contrast by monitoring changes in the optical path 
length caused by the photothermal effect [21] via phase-sensitive OCT. The primary 
contrast agent used with PTOCT is gold nanoparticles. It has also been shown to have 
some limited sensitivity to hemoglobin [22]. Magnetomotive OCT (MMOCT) exploits 
induced magnetic motion to enable molecular contrast in OCT. Since human tissues 
have a low magnetic susceptibility, the introduction of targeted magnetic particles to 
tissues enables MMOCT to provide highly sensitive molecular contrast [23]. An external 
electromagnet is modulated to induce nanometer scale motion which is then detected by 
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phase-sensitive OCT. MMOCT has been used to image superparamagnetic iron oxides 
(SPIO) which are more commonly known for their use as MRI contrast agents [24,25]. 
Spectroscopic OCT [26] exploits the broad spectrum light sources used for OCT to 
garner absorption contrast. Spectral windows with different center wavelengths are 
typically formed in post processing to provide spectral resolution at the price of spatial 
resolution [27-29]. These techniques work best for highly peaked absorption spectra 
which can readily be separated from scattering based on their unique shape. Recent work 
using wavelengths down into the visible were able to measure absorption due to 
hemoglobin and blood oxygen saturation [30]. PPOCT integrates OCT with the pump-
probe spectroscopy to provide molecular contrast. The pump-probe technique has been 
widely employed in experimental molecular physics to measure excited electronic states 
and molecular dynamics. It is well suited to imaging molecular chromophores like 
hemoglobin and methylene blue. It has a couple of advantages over spectroscopic OCT 
which is similarly sensitive to molecular chromophores. Contributions from absorption 
and scattering are easily separated so the absorption spectrum need not be highly peaked 
over the spectral bandwidth of the system. It has higher molecular specificity since there 
must be a resonance at both the pump and probe wavelengths. The molecular specificity 
can be improved by measuring the excited state lifetime. The excited state lifetime can 
also be used to measure quenching of the excited state, a mechanism commonly used in 
optical sensors for measuring changes in molecular concentration, e.g. oxygen. An 
obvious disadvantage compared to spectroscopic OCT is the increased complexity of the 
optical system, however in our most recent work I have largely mitigated this issue 
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adding very common pump laser sources to an otherwise typical OCT system. An 
additional important point to make is that while PPOCT may use a pump in the visible, 
all of the applications we are proposing would use a probe in the near IR. Since the 
pump only needs to go it into the tissue (not back out like the probe) and we can tolerate 
multiple scattering events, we do not expect visible pump wavelengths to significantly 
limit the imaging depth of PPOCT. Especially, PPOCT is unique among the few 
available techniques for molecular contrast in OCT in that it can measure the excited 
state lifetime of the contrast agent which can be very sensitive to the local environment.  
As an exogenous contrast agent, MB has a well-characterized singlet ground state 
absorption in the visible wavelength range and a triplet state absorption in the near 
infrared (NIR) range [31]. Also, MB is one of the few dyes that have been widely used 
for clinical applications. It was originally used as an antimalarial drug in the early 20th 
century and was the first synthetic drug [32]. More recently, methylene blue has been 
investigated for photodynamic therapy [33] and chemotherapy for melanoma [34] 
Additionally, MB has been shown to selectively stain specialized columnar epithelium in 
Barrett’s esophagus [35]. In the presence of oxygen, the lifetime of the MB excited 
triplet state is dramatically decreased, causing variations up to a few microseconds. The 
transfer energy within the oxygen molecules and the formation of the singlet oxygen 
causes to decrease the lifetime by a few microseconds [36]. This phenomenon makes 
MB as useful as an oxygen sensor.  
Although MB has been utilized in the medical filed, it has photo toxicity to the 
applied area [37]. Also, pure MB is rapidly converted to its colorless leuco-methylene 
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blue (LMB) that decreases absorption peak under caused by photobleaching and oxygen 
presenting [38]. PPOCT signal intensity is theoretically related to the scattering and 
absorption coefficient of a target sample [39]. In order to make MB more proper as the 
contrast agent using in vivo PPOCT, solvent evaporation technique using poly lactic-co-
glycolic acid (PLGA) as the polymer is useful to encapsulated MB within a polymer 
shell [40]. PLGA is biocompatible, biodegradable, and has FDA approval [41]. It is 
commonly used for applications in drug delivery and tissue engineering. Given that both 
PLGA and MB are biocompatible and used clinically, their combination should yield a 
contrast agent that is well tolerated with the potential for eventual FDA approval. A 
microencapsulated MB contrast agent that offers several advantages over bare MB for in 
vivo PPOCT imaging. First, since the PPOCT signal is a function of both the scattering 
and transient absorption, scattering from the polymer used to encapsulate MB improves 
the PPOCT signal. Second, MB is photobleached to colourless LBM in vivo, thus 
diminishing the PPOCT signal since LMB is transparent at 663 nm. Microencapsulation 
sequesters the MB and prevents the reduction reaction. Finally, the surface of the 
polymer can be readily functionalized to enable active tagging of various receptors. 
While MB could also be functionalized for active tagging, it would risk altering the 
excited state dynamics that enable PPOCT via the transient absorption of the triplet state.  
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1.2 Objective and dissertation outline 
The goal of the project is to develop a molecular contrast-enhanced system with 
OCT to image endogenous or exogenous contrast agent. These aims are reached using 
the following steps. 
To begin, PPOCT system is designed and developed. In order to detect sensitively 
the signal from the endogenous or exogenous target molecule, a signal-processing 
algorithm is also optimized. The main OCT system is based on spectral-domain OCT 
(SDOCT) to have a few millimeters imaging penetration with a micron-scale imaging 
resolution. Depending on the absorption peaks of the target molecule, the wavelength of 
a pump and a probe light source is selected. As a part of the development, the system is 
validated calculating Signal-Noise-Ratio (SNR) and Contrast-Noise-Ratio (CNR) the 
measured PPOCT signal. 
As a test of the PPOCT imaging system capabilities in a realistic ex or in vivo 
settings, Hemoglobin (Hb) and methylene blue (MB) are used as the target molecule. As 
an initial test, the Hb and aqueous MB were imaged in a capillary tube. We also 
demonstrate a pump-probe OCT (PPOCT) system capable of measuring molecular 
contrast-enhanced signal from a live animal. Xenopus tadpoles and zebra fish in 
particular have been chosen because they are a frequent target for optical imaging due to 
their size and relative translucence, and the fact that they are a common model for 
developmental biology [42]. Especially a zebra fish in larval stage was stained with MB 
by submersion in a 0.01% (w/v) solution of MB for 6 hours. The PPOCT image 
collected from the zebra fish is evaluated a PPCOCT system’s capability to provide 
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morphological and molecular contrast-enhanced images that can be correlated to each 
other and to the corresponding histology. 
In order to expand the application of the molecular contrast-enhanced system with 
OCT on the clinical field such as intravascular optical imaging in arteries using catheter 
endoscopes, it is necessary to use very broad spectral bandwidths (near UV to short-
wave IR) and specialized optical fibers, such as double-clad fiber, and have the capacity 
to accommodate high rotational velocities. A lensless fiber optic rotary joint (FORJ) 
based on co-aligning and placing in contact two optical fibers is developed. The 
capability of developed lensless FORJ is demonstrated with a wide range of wavelength 
(355~1360nm) and high rotational velocities.  
In order to overcome the limitations of MB as a contrast agent for in vivo 
PPOCT, microencapsulated MB is fabricated based on PLGA. The capability of a MB 
microsphere as a new contrast agent for PPOCT was tested. As an initial demonstration 
simulated with biological conditions, the MB microspheres is imaged in a 100 µm 
diameter capillary tube submerged in a 1% intralipid emulsion and on the gelatin based 
artificial tissue. In order to use a MB microsphere as the oxygen sensor, the lifetime of 
transient absorption and relative phase shift are measured using time-resolved Pump-
Probe spectroscopy and PPOCT by varying the oxygen concentration from 0% to 21%. 
This dissertation mainly is composed with the design, development and 
validation of molecular contrast-enhanced system and a new contrast agent for OCT. 
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Based on the aforementioned objectives, this dissertation has been organized as 
follows: 
 Chapter 2 does primarily be dedicated to the former, i.e. techniques that derive 
their molecular information directly from OCT images. It provides some basic 
understanding of the physical process being exploited, noting some of the distinct 
properties of each technique, along with the essential technical details of the optical 
system. Subsections introduce each technique of molecular contrast-enhanced OCT 
system. 
Chapter 3 describes the design and development of the PPOCT system, and 
provides experimental ex/in vivo results. 
Chapter 4 shows the lensless and ultra-wideband fiber optic rotary joint for 
endoscopic molecular-enhanced OCT imaging, and also describes how the performance 
of FORJ was tested.  
Chapter 5 discusses the design and development of the microencapsulated MB 
using PLGA as a new contrast agent for PPOCT. First subsection describes the how the 
microencapsulate MB was tested for PPOCT. Second subsection deals with how the 
microencapsulated MB works using PPOCT as the oxygen sensor. 
Parts of [1] have been dealt with permission and arranged throughout the 
dissertation. 
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2. MOLECUALR IMAGING IN OPTICAL COHERENCE TOMOGRAPHY* 
 
This chapter primarily deals with the former, i.e. techniques that derive their 
molecular information directly from OCT images. It provides some basic understanding 
of the physical process being exploited, noting some of the distinct properties of each 
technique, along with the essential technical details of the optical system. Subsections 
introduce each technique of molecular contrast-enhanced OCT system. 
2.1 Photothermal OCT 
2.1.1 Theory of Photothermal OCT 
Photothermal OCT (PTOCT) provides absorption based contrast by monitoring 
changes in the optical path length caused by the photothermal effect [43]. In the 
photothermal effect, photons are absorbed by chromophores within a sample causing a 
localized rise in temperature. Thermoelastic expansion caused by the photothermal effect 
generates isolated variations in the refractive index which in turn generates a variation in 
the optical path length [44]. The optical path length variations typically generated by the 
photothermal effect, often nanometer in scale, can be resolved with phase-sensitive OCT 
[45, 46]. 
PTOCT utilizes separate laser sources for photothermal excitation and OCT 
signal generation. The photothermal source is coupled into the sample arm of the OCT 
                                                
*  Reprinted with permission from [1] P Mattison, Scott, Wihan Kim, Jesung Park, and Brian E Applegate. 
"Molecular Imaging in Optical Coherence Tomography." Current molecular imaging 3, no. 2 (2014): 88-
105. 
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system. Amplitude modulation of the photothermal source enables the differentiation of 
photothermal heating from the scattering signal [46]. Selecting the ideal wavelength for 
absorption by the target chromophore enables specific molecules to be targeted. Figure 1 
depicts a typical schematic for performing PTOCT. 
 
 
Figure 1: Schematic diagram of the photothermal phase sensitive spectral domain optical coherence 
tomography system. Reprinted with permission from [47] 
 
In most applications of PTOCT, a series of temporally resolved depth scans (M-
mode scans) are obtained. Following a Fourier transform of the OCT phase data at each 
point in depth, the magnitude of the PTOCT data is located at the modulation frequency 
of the photothermal laser[46, 48]. Prior studies have investigated the relationships 
between the magnitude of PTOCT signal and the concentrations of the target 
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chromophores [46, 48]. Additionally, a relationship has been demonstrated between 
PTOCT signal and the intensity of the photothermal source. The magnitude of the phase 
shift generated in the OCT signal, Δφ, is related to the change in refractive index per unit 
temperature of the sample, , the thermal conductivity, k, the center wavelength, λ, 
the concentration of the absorbing sample, and the size of the excitation volume [48-51]. 
For gold nanoparticles, a common target of photothermal OCT, the phase shift, elicited 
by the photothermal response can be approximated by Eq. 1 [48].  ∆𝜙 = .64 '(') *+ ,(./)1 𝑁𝜎     (1) 
Where N is the number of gold nanoparticles in the optical excitation volume, and 𝐼 𝑟  
is the intensity of the photothermal source. 
A variety of work has gone into improving the sensitivity of PTOCT. As Eq. 1 
shows, the magnitude of the PTOCT signal is linearly dependent upon the optical 
intensity of the photothermal source as well as the concentration of the targeted 
chromophore. However, as the modulation frequency of the photothermal source 
increases, the signal strength decreases logarithmically [49]. A range of modulation 
frequencies from 25 Hz up to 120 kHz have been explored. Due to the logarithmic 
decrease in signal with modulation frequency, there is a trade-off between image speed 
and signal strength. Additionally, while the amplitude of the OCT signal does not 
directly impact the intensity of the PTOCT signal, lower OCT signal amplitude increases 
the noise of PTOCT. Complex post processing algorithms have been attempted to 
increase phase sensitivity, including averaging of overlapping short time Fourier 
n
T
¶
¶
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transforms [49], subtraction of frequency components to compensate for additive noise 
[51], and polynomial background order subtraction [48, 52].  
An alternative approach for monitoring the photothermal signal has been explored 
through photothermal optical lock-in optical coherence microscopy (OCM). Phase 
modulations are generated in the reference arm to match the amplitude modulation 
frequency of the heating beam. The result is a demodulated photothermal signal of the 
absorbers without the need for m-mode scanning [53].  
2.1.2 Applications 
Photothermal OCT is often used to monitor exogenous contrast agents, most 
notably gold nanoparticles. In addition to their biocompatibility, gold nanoparticles are 
desirable because they have established methods for molecular targeting, and can easily 
be used for photothermal therapy [54]. PTOCT imaging of immunotargeted gold 
nanoparticles has been demonstrated by Skala, et al for detection of epidermal growth 
factor receptor (EGFR) [48]. EGFR is a cell surface receptor which binds specific 
ligands, and mutations to EGFR which have been linked to the formation of cancer [55, 
56]. To target EGFR, gold nanospheres were conjugated with EGR specific antibodies. 
The targeted nanospheres were placed in cell cultures expressing EGFR (Figure 2(a)) 
and cell cultures with no expression of EGFR (Figure 2(b)). Additionally, non-targeted 
nanospheres were added to cell culture containing cellular overexpression of EGFR 
(Figure 2(c)). Figure 2(d) demonstrates the specific targeting of the antibody conjugated 
nanoparticles to cellular expression of EGFR. 
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Figure 2: Images of EGFR expression in three-dimensional cell constructs containing EGFR+ cells 
(MDA-MB-468) with and without antibody-conjugated nanospheres (a and c, respectively) and EGFR-
cells (MDA-MB-435) with antibody-conjugated nanospheres (b). There was a significant increase in the 
photothermal signal from EGFR overexpressing cell constructs labeled with antibody conjugated 
nanospheres (d) compared to the two controls (EGFR+/Nanosphere- and EGFR-/Nanosphere+). N = 17 
images for each group, (*, p < 0.0001). Pump power 8.5 kW/cm2. Reproduced with permission from [48]. 
 
 To the best of our knowledge, this is currently the only documented use of a 
targeted contrast agent for PTOCT imaging of nanoparticles. However, gold 
nanoparticles have widely been used for targeted molecular contrast for various 
applications [58]. Tumors are also often passively labeled with gold nanoparticles via the 
enhanced permeability and retention effect [59]. Other exogenous contrast agents have 
been demonstrated in the form of carbon nanorods [52], polypyrrole nanoparticles [60], 
indocyanine green encapsulated by poly (lactic-co-glycolic) acid nanoparticles [61], and 
iron oxide-silica-gold nanoprobes [62].  
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While PTOCT has largely been applied to exogenous contrast agents, it can 
potentially be used to image a variety of endogenous chromophores. If we take guidance 
from photoacoustic microscopy, which operates via a similar contrast mechanism, there 
is the potential to generate PTOCT images targeting nucleic acids, cytochromes, 
hemoglobin, and melanin [63-65]. To date only hemoglobin has been successfully 
measured with PTOCT. Milner and coworkers developed a dual wavelength PTOCT 
system to characterize the oxygen saturation of hemoglobin. Using 780 nm and 800 nm 
pump wavelengths coupled with a 1064 nm center wavelength OCT system the oxygen 
concentration of hemoglobin in a 300 µm microvessel phantom was monitored. Figure 
3(a) shows an en-face image of this sample, while Figure 3(b) shows a b-scan of the 
region of interest. Using a dual wavelength approach enables PTOCT to monitor the 
oxygenation of blood. [66]. Figure 3(c) compares the measured oxygen concentration of 
porcine blood via PTOCT compared to a reading taken using a commercial oximeter 
[67]. 
The interest in PTOCT is a rapidly expanding, especially for applications with 
gold nanostructures. Gold nanoshells and similar plasmonic nanostructures are being 
investigated for a number of biomedical applications that exploit their tunable plasmon 
resonances, including biomolecular sensing [68, 69], imaging [70, 71], and diagnostics 
[72, 73]. They are also under investigation for therapy with ongoing clinical trials for the 
treatment of primary prostate cancer and primary and/or metastatic lung tumors [74]. 
Robust PTOCT imaging technology has the potential to make an impact across many of 
these areas of interest.  
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Figure 3: (a) B-scan PTOCT image of an arterial-venous phantom sample. (b) Blood SO2 level measured 
by DWP-OCT (vertical) versus oximeter values (horizontal). Blood is stationary for all measurements. 
Modified from [67]. 
 
 
2.2 Spectroscopic OCT 
2.2.1 Theory of SOCT 
Absorption spectroscopy is a common analytical tool used to identify specific 
molecules, sometimes in very complex samples, not unlike biological tissues. All 
molecular species have the capacity to absorb light. The absorption spectrum is 
characteristic of a particular molecular species, but also sensitive to environment. The 
broad spectral bandwidth of low-coherence light sources used in OCT, especially those 
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used for ultrahigh resolution, are well suited to measuring absorption spectra. Thus, a 
natural method to achieve molecular contrast via OCT is through what is known as 
spectroscopic OCT (SOCT) [75] which exploits the broad spectrum light source to 
garner absorption contrast. 
In SOCT there is always a competition between the desire for high spatial 
resolution and high spectral resolution. Both cannot be simultaneously satisfied leading 
to the development of a variety of approaches to the inevitable compromise. The 
approaches, in general, fall into two categories, those that make the compromise in 
hardware by selecting several light sources with different center wavelength [76, 77] and 
those that make the compromise in software using post processing algorithms and a 
single broadband light source [78-81]  
One hardware approach uses three light sources to triangulate a peak in the absorption 
spectrum of a target chromophore [77]. The center wavelength of one source is chosen to 
coincide with the peak absortion while the other two wavelengths are chosen to coincide 
with low absorption regions above and below the peak. This method enables the 
identification of the peak in the attenuation and therefore separate attenuation due to 
scattering which is approximatelly linear over this range from attenuation due to 
absorption. Using this approach, Yang et al. [77] imaged indocyanine green in a 
Xenopus Laevis tadpole. A limitation of this approach is the requirement to select source 
wavelengths based on a priori knowledge of a given chromophore absorption spectrum.  
More commonly, SOCT is performed in post-processing of broadband OCT data via 
time-frequency transform. This approach is more versatile, enabling the adaptation of the 
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algorithm for each target chromophore in the sample. A detailed discussion of the 
competing algorithms is beyond the scope of this review. A discussion may be found in 
the literature [82] [79] [83], for the pros and cons of three commonly used methods for 
obtaining spectral data in SOCT, the short-time Fourier transform, the wavelet transform 
and the Wigner-Ville distribution. 
Wax and coworkers [78] have recently developed an algorithm that incorporates 
two STFTs, one with a narrow spectral window and one with a broad spectral window. 
The two TFDs are multiplied point by point to generate a TFD with both high spatial and 
spectral resolution. The net result minimizes the trade-off between spectral and spatial 
resolution. Recently, Bosschaart, et al, published a quantitative comparison of short-time 
Fourier transforms and the dual window approach with respect to monitoring the 
concentration and oxygen saturation of hemoglobin [84]. In addition to the tradeoff 
between spatial and spectral resolution, Bosschaart, et al, discuss the importance of 
obtaining accurate spectral information when quantifying the concentration of 
chromophores. 
2.2.2 Applications of SOCT 
SOCT can gain contrast from a variety of exogenous chromophores, including 
the catalogue of commercially available fluorescent dyes primarily used for fluorescence 
microscopy. The best contrast agents possess a strongly peaked absorption spectrum in 
the range of the broadband source to be used. A discussion of common near infrared 
dyes well suited for use in SOCT can be found in the literature [85]. Gold nanoparticles 
have also been utilized for absorption based contrast [48, 86]. Varying the size and 
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geometry gold nanostructure enables tuning of the peak of the absorption spectrum [87] 
to match the broadband source. Custom nanoparticle contrast agents have also been 
explored for use with true-color spectroscopic optical coherence tomography [88].  
 
 
Figure 4: Representative classification of lipid plaque phantom. Two sites within volumetric data set are 
shown in (a-d) and (e-h). (a,e) Histology taken through two cross sections within phantom plaque, 
showing void created by injection of fat emulsion. Corresponding H&E and oil-red-o stains respectively 
showing void created by the injection of a fat emulsion within center of plaque. (b, f) Optical frequency 
domain imaging (OFDI) image of phantom lipid plaque corresponding to histology shown in panels a and 
e respectively. OFDI image shown in panel b is taken through the center of the artificial plaque whereas 
panel f is taken from the edge of the plaque. (c,g) Probability of cholesterol image derived from the output 
of the classification algorithm. A high probability of cholesterol is measured from the OFDI image taken 
through the center of the plaque. A low probability of cholesterol is measured through the edge of the 
plaque. (d, h) Classification and probability image utilizing a Hue-Saturation-Value (HSV) convention 
where hue encodes class (red-other, yellow- cholesterol) and saturation and value encode probability. (i) 
Depth resolved integration of cholesterol probability. (j) Depth resolved integration of collagen 
probability. Within chemograms, lipid plaque can be seen as a circular region with increased cholesterol 
(i) and decreased collagen probability (j). Low probability of lipid was coded as black and high probability 
of lipid was coded as bright yellow. Low probability of collagen was coded as black and high probability 
of collagen was coded as bright red. Scale bar = 1mm. Reproduced from [78].  
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Endogenous contrast has been widely explored for SOCT. Early work monitored 
the absorption due to water in the cornea through SOCT [89]. More recently, the 
potential for utilizing SOCT to monitor the lipid content of atherosclerotic plaques has 
been investigate [90]. Atherosclerotic phantoms were generated by injecting lipid pools 
into freshly excised porcine arteries and imaged using a 1300 nm center wavelength FD-
OCT system. To obtain spectrally resolved images of the sample, short time Fourier 
analysis was performed on the raw OCT data. Figure 4 illustrates the system sensitivity 
to lipid within the sample. The authors compensate for the overlapping spectra of 
endogenous chromophores through preprocessing to smooth the spectra as well as 
statistical analysis to determine the presence of lipids [91].  
The most common endogenous target for SOCT imaging has been hemoglobin 
[92, 93]. SOCT has been explored both as a way to map vasculature and as a way to 
measure blood oxygen saturation [94]. Robles and coworkers demonstrated the use of a 
dual window approach, noted above, along with a broadband short wavelength (455-695 
nm) source for imaging blood oxygen saturation. Using a mouse window chamber 
model, they were able to measure oxygen saturation in vivo. Figure 5 depicts tissue 
contrast as well as SO2 measurements in an en face image. 
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Figure 5: (a) En face METRiCS OCT image with arrows indicating points where the spectra are extracted. 
White x and y scale bars, 100 µm. (b)–(e) Spectral profiles from corresponding points in (a). Measured 
spectral profiles (black) are superposed with the theoretical oxy- (dashed red) and deoxy- (dashed blue) 
hemoglobin normalized extinction coefficients, and normalized absorption of NaFS (dashed green). Also 
shown are the SO2 levels and the relative absorption of sodium Fluorescence (NaFS) with respect to total 
hemoglobin (Hb) (ε ≡ NaFS/Hb). All spectra were selected from depths immediately below each 
corresponding vessel. Reprinted with permission from [49]. 
 
The development and application of SOCT is in part driven by the fact that it can 
largely be implemented as a post-processing algorithm. Hence, it could be widely 
adapted to current OCT systems including commercial devices used clinically. That 
being said a confounding factor is that SOCT works best when the absorption spectrum 
of the target chromophore(s) have a distinct peak in the wavelength band of the light 
source. For exogenous contrast that largely restricts SOCT imaging to near IR dyes. For 
endogenous chromophores the OCT system sometimes has to be adapted to the 
absorption spectrum of the chromophore. For instance, the blood oxygen saturation 
measurements highlighted above used an atypical short wavelength range OCT system 
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in order to overlap with the distinct visible absorption peaks of oxy and deoxy 
hemoglobin. Such choices can have an impact on other performance metrics for the OCT 
system such as the imaging depth.  
2.3 Magnetic Contrast Agents for OCT 
2.3.1 Theory of magnetic contrast agents for OCT 
Magnetomotive OCT (MMOCT) exploits induced magnetic motion to enable 
molecular contrast in OCT. Since human tissues have a low magnetic susceptibility, the 
introduction of targeted magnetic particles to tissues enables MMOCT to provide highly 
sensitive molecular contrast [95]. Modulated magnetic fields are generated within the 
sample arm of the OCT system to induce movement or spin of magnetic particles. 
Movement of the particles can be detected by monitoring the phase of the OCT system, 
whereas spin can be detected as amplitude modulations [96].  
MMOCT is typically implemented in phase sensitive OCT systems through the 
addition of an electromagnet to the sample arm as illustrated in Figure 6. To enable 
frequency domain detection, a sinusoidal modulation is applied to the magnetic field. 
Localized heating may occur at modulation frequencies greater than 100kHz [97]. 
Imaging is typically imaging with modulation frequencies on the order of 10s of Hz. It 
has been noted in the literature that increasing the strength of the magnetic field yields 
diminishing returns, with high field strengths eventually resulting in saturation of the 
magnetic movement [98, 99].  
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Figure 6: Biological magnetomotive optical coherence elastography (MM-OCE) setup. A standard 800 nm 
spectral-domain OCT system is used with an electromagnetic coil placed in the sample arm. A magnetic 
field strength of approximately 400Gwas used to perturb the magnetic nanoparticles (MNPs) inside the 
sample and changes in the magnitude and phase of the interference pattern were detected in synchrony 
with the A-line scan rate and activation of the magnetic field coil. Reprinted with permission from [100]. 
 
MMOCT has primarily been used to image exogenous contrast agents. Other 
imaging modalities, such as magnetic resonance imaging [101], x-ray luminescence 
tomography [102], and single photon emission computed tomography [103], have driven 
the development of magnetic nanoparticles which may also serve as contrast agents for 
MMOCT. The most prevalent of these magnetic nanoparticles are superparamagnetic 
iron oxides (SPIOs). SPIOs are ideal for MMOCT because they have sufficient magnetic 
susceptibility, proven molecular targeting, and have previously been approved by the 
FDA for in vivo contrast agents in MRI. The primary endogenous magnetic target is 
hemoglobin (Hb). The high concentration of hemoglobin in red blood cells enables them 
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to serve as targets for MMOCT [104]. However, in vivo imaging of hemoglobin with 
MMOCT is confounded by the fact that the red blood cells are also moving. 
2.3.2 Applications of MMOCT 
MMOCT has been utilized in targeted applications of magnetic nanoparticles to 
detect a variety of pathologies. The potential for MMOCT to image atherosclerosis, a 
disease in which the arterial wall thickens due to the buildup of fats [105], has been 
explored through selective targeting of key molecular and cellular components. Oh et al 
demonstrated the ability to detect iron oxide nanoparticles taken up by macrophages in 
an atherosclerosis animal model [106]. More recently, Kim, Ahmad, and coworkers 
targeted magnetic nanoparticles to αvβ3, an integrin overexpressed in atherosclerosis, by 
functionalizing the surface of the nanoparticle with the arginine-glycine-aspartic acid 
(RGD) tripeptide. This technique enabled MMOCT to detect ex vivo atherosclerotic 
lesions with high specificity. Figure 7 illustrates the results of this research [107]. The 
same surface modification can be utilized to target cancerous tissues. In breast cancer, 
αvβ3 and Her2 receptors are often overexpressed [108]. These receptors can be targeted 
by functionalizing the surface of magnetic nanoparticles with the RGD tripeptide [109].  
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Figure 7: Biological Representative MMOCT images from the ex vivo aorta specimens. The visual 
appearance of the luminal walls of the aortas (a–c) and corresponding histological sections (d–f) reveal the 
development of early-stage fatty streaks and plaques with lipid cores. OCT structural images (g–i) were 
superimposed (m–o) with magnetomotive images (j–l). The cross-sectional MMOCT images correspond 
to the yellow scan lines shown in (a–c). The red and green channels represent the structural OCT intensity 
and MMOCT signal, respectively. Reprinted with permission from [107].	 
 
As a substitute for targeting magnetic nanoparticles to specific cells or molecular 
signals, cells may be tagged in vitro then introduced to a living sample. Two previous 
studies performed by Oldenburg et al have demonstrated the capability to image 
magnetically tagged platelets, small cell fragments involved in the wound healing 
process, using MMOCT. Dextran coated SPIOs were uptaken by platelets and 
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introduced into both in vitro and ex vivo samples to track the location of injured 
vasculature [99, 100]. When contacting activating factors, such as collagen, platelets will 
aggregate at a region of injury, initiating the clotting of blood [111]. Figure 8 depicts the 
aggregation of SPIO tagged platelets at the site of an injury in vasculature [110]. 
 
 
Figure 8: OCT (red) and MMOCT (green) of ex vivo porcine arteries exposed to SPIO loaded rehydrated 
lyophilized (SPIO-RL)platelets in a flow chamber. MMOCT contrast is specific to the artery that was 
injured, due to specific adhesion of SPIO-RL platelets. Lower right inset: TEM of an SPIO-RL platelet, 
1 µm scalebar. Reprinted with permission from [110].  
 
The fact that there exists FDA approved SPIOs means that MMOCT could make 
it to clinical application with off-label use of the SPIOs even with only very limited 
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clinical applications. An additional advantage is that much of the labeling chemistry has 
been worked out such that SPIOs can readily be target to key indicators of pathologies 
such as cancer and atherosclerosis. Outside of molecular contrast, MMOCT has been 
shown to potentially be useful for enhancing signal in optical coherence elastography 
[100] [112]. 
2.4 Second Harmonic OCT 
2.4.1 Theory of second harmonic OCT 
Second harmonic optical coherence tomography (SHOCT) provides OCT with 
contrast via the non-linear process of second-harmonic generation (SHG). SHG 
fundamentally refers to the phenomena where two photons simultaneously interact with 
a noncentro-symmetric material and combine to generate a single photon with twice the 
frequency (half the wavelength) [113]. Second harmonic generation is a coherent 
process, hence directly detectable using low coherence interferometry.  
SHOCT requires the use of a femtosecond laser source due to the fact that the 
second harmonic signal is inversely proportional to the pulse duration of the light source. 
As a consequence SHOCT is only compatible with spectrometer based OCT or time-
domain OCT, i.e. it is incompatible with swept-source techniques. A second requirement 
is a nonlinear medium, typically a nonlinear crystal, in the reference arm to generate the 
second harmonic reference signal. Otherwise, the SHOCT optical system can take on 
any geometry normally used for OCT. Figure 9 illustrates a typical setup of a SHOCT 
system. Two spectrometers are necessary in order to collect the backscattered near IR 
(fundamental) light as well as the visible (second harmonic) light. Depth resolution 
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occurs in the same way as for standard OCT except the SHOCT signal is only generated 
in the tissue where there is noncentro-symmetric media, typically collagen. A SHOCT 
system is usually setup to have better lateral resolution than a typical OCT system 
because there is an added benefit to the second harmonic signal strength which is 
proportional to the square of the fundamental light intensity. 
 
 
Figure 9: Schematic of the SD SH-OCT layout. The solid gray line represents the fundamental beam path, 
and the dotted black line represents the beam path for the secondharmonic light. Spectnω , spectrometer 
designed for the nth harmonic; DG, diffraction grating; Det, detector; OBJ, objective; NA, numerical 
aperture. Reproduced from [114]. 
 
2.4.2 Applications of second harmonic OCT 
As noted above the most efficient second harmonic source in biological systems 
is collagen. The triple helical structure of collagen provides the necessary noncentro-
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symmetric geometry necessary for SHG [115, 116]. Collagen has been the target from 
the earliest example of SHOCT imaging in tissue [117]. An example SHOCT image 
[118] of rat tail tendon is show in Figure 10(a). Many of the morphological structures 
that are responsible for the mechanical properties of the tendon can be seen in the image, 
which correlate well with the structures seen in the polarization microscopy image in 
Figure 10(b).  
 
 
Figure 10: (a) SH-OCT image showing an area of 100 × 50 µm in the rat-tail tendon, where many cable-
like, parallel oriented, and slightly wavy collagen fiber bundles (fascicles) can be visualized; (b) 60X 
polarization microscope image of the same sample (scale bar: 10 µm). Reproduced with permission from 
[118]. 
 
Additional information may be extracted from SHOCT by measuring the 
polarization dependence of the SHOCT signal. This dependence can be quantified with 
the anisotropy parameter,	𝛽 = (𝐼∥ − 𝐼:)/(𝐼∥ + 2𝐼:), where 𝐼∥ and 𝐼:are respectively the 
intensity of parallel and perpendicular linear polarization second harmonic signals 
emitted from the sample. The anisotropy parameter should vary depending on the 
relative orientation of the collagen fibrils. Applegate et al. [119] demonstrated the first 
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polarization resolved imaging on a sample of salmon skin shown in Figure 11. 
Depending on the polarization state, the SHG signal varied across the sample, Figure 
11(a) and (b). Vector addition of the signals from the two polarization states lead to the 
polarization independent image shown in Figure 11(c). Finally, Figure 11(d) is a map of 
the anisotropy parameter indicating the relative orientation of the collagen fibrils. 
 
 
Figure 11: (a) SHOCT image of the overlap of three fish scales, recorded with the reference-arm second- 
harmonic light polarization parallel to the fundamental light polarization. (b) SHOCT image recorded with 
the reference-arm second-harmonic light polarization perpendicular to the fundamental light polarization. 
(c) Polarization-independent image derived from (a) and (b). (d) Image of the anisotropy parameter, β. 
Reprinted from [119]. 
 
Currently, SHOCT is somewhat limited by the prevalent forward scattering of 
SHG light from collagen. The forward scattered light may be backscattered by a deeper 
reflector in the sample, confounding localization of the collagen which generated the 
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second harmonic signal. To the best of our knowledge, no exogenous SHG agent has 
been demonstrated in the literature for SHOCT, further limiting its application. 
2.5 Optical Multimodality Imaging with OCT 
2.5.1 Background 
Thus far we have focused on reviewing imaging technologies that somehow 
derive molecular information from the OCT signal. A second path to the desired end 
result, an imaging technology that can effectively probe both morphological and 
biochemical pathological changes in tissue, is to combine modalities. In many cases, 
individual optical imaging modalities have demonstrated promising results for 
differentiating between healthy and diseased tissues and cells. However, the complex, 
pathological mechanisms of disease progression limit the diagnostic accuracy using 
individual modalities. Combining two or more optical imaging modalities to provide 
different optical responses of biological samples improves the accuracy, sensitivity and 
specificity for early diagnosis. In general, the optical multimodality imaging is 
constructed by combining morphological and functional imaging modalities. As OCT is 
an excellent morphological imaging modality, a variety of research combining OCT and 
functional imaging modalities such as steady-state fluorescence spectroscopy [121-123], 
time-resolved fluorescence lifetime imaging microscopy (FLIM) [120, 121], florescence 
laminar optical tomography [126, 126] and Raman spectroscopy [127, 128] have been 
studied for acquiring complementary optical responses of biological samples. 
A multimodality imaging system combining OCT with other functional imaging 
modalities is typically constructed by partially or fully combining optical and 
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mechanical parts, light sources and data acquisition. Figure 12 is an example of a 
multimodal system that combines OCT and FLIM by using a common set of imaging 
optics, but otherwise remains two distinct imaging systems. 
 
 
Figure 12: Schematic diagram of the multimodality imaging system by combining OCT and FLIM 
subsystems. L1, L2 and L5: free-space collimation and coupling lenses, L3, L4, L6-L12: fiber-connected 
collimation and coupling lenses, NDF: neutral density filter, M1-M4: mirrors, DM1-DM4: dichroic 
mirrors, and F1-F4: filters. Reprinted with permission from [123]. 
 
2.5.2 Applications of optical multimodality imaging with OCT 
A Fluorescence is widely used as a method of identifying molecular species. The 
unique fluorescent characteristics of endogenous (e.g. collagen, elastin and NADH) and 
exogenous (e.g. luciferase, indocyanine green and fluorescein) fluorophores have been 
measured by steady-state (intensity) and/or time-resolved (lifetime) fluorescence. 
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Changes in characteristic fluorescence with the onset of pathological changes in tissues 
have been investigated for diagnosing and monitoring various diseases.  
Simultaneous measurement of morphological and biochemical information by 
combining OCT and different fluorescence detection modalities increase the sensitivity 
and specificity for detecting cancers [120-122] and atherosclerotic plaques [124]. Barton 
et al. developed a multimodality imaging system by combining OCT and steady-state 
laser-induced fluorescence (LIF) spectroscopy for diagnosis of ovarian [121] and colon 
[122] cancers, and designed an OCT/LIF miniature endoscope for animal and clinical 
studies [123]. Figure 13 demonstrates OCT images and corresponding histology of solid 
sex cord-stromal tumors (SCST) (a-d) and LIF spectral comparison of all experimental 
groups (f) with murine ovarian model. They reported that OCT images of solid SCST 
shows rapid attenuating homogeneous masses and large vascular spaces adjacent to 
neoplastic masses compared to control tissues. In LIF spectra, 390nm peak is greater 
than 450nm peak due to high collagen content from thin collagenous capsule and 
decrease NADH content with slowly proliferating neoplasm with sensitivity of 88% to 
SCST and specificity of 60% to normal cycling ovaries [121]. 
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Figure 13: Solid SCST and Life spectral curves. (a) and (b) OCT image of ovary with solid SCST and 
corresponding histology. (c) and (d) OCT image of solid SCST within benign and corresponding 
histology. (e) Solid spectral curves. SCST: sex cord-stromal tumor, arrow: benign cyst lining, asterisk: 
vascular spaces, C: adjacent benign cyst, Scale bar: 500 µm, Con: Control, VCD: 4-vinylcyclohexene 
diepoxide, DMBA:7,12-dimethylbenz[a]anthracene, Grouping (IP injection/Ovarian injection). Reprinted 
with permission from [120]. 
 
A multimodality OCT/FLIM system was developed to simultaneously acquire 
co-registered OCT and autofluorescence FLIM images for detection of oral cancer using 
in vivo hamster model [120] and atherosclerotic plaque using ex-vivo human coronary 
arteries [124]. Compared to the steady-state LIF system providing fluorescence intensity 
only, FLIM can provide fluorescence intensity as well as lifetime as a function of 
wavelength. The advantage of using lifetime information over intensity is that it is more 
stable in the experimental environment including motion artifact of samples and 
variation of excitation pulse energy, which is a critical factor for clinical measurement. 
Figure 14 shows a volumetric (a) and cross-sectional (b) OCT structure images of a 
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squamous cell carcinoma (SCC) area in an in vivo hamster check pouch, a related 
histopathology (c) and en-face fluorescence intensity and lifetime images at three target 
wavelength channels (d). The SCC tumor was significantly thicker (~1mm) than normal 
oral mucosa (~0.4 mm) and lost the layered structures, as shown in the OCT volume. 
The fluorescence intensity and lifetime of malignant tissue followed the characteristics 
of both NADH and FAD, suggesting the autofluorescence emission of malignant tissue 
[120]. 
Another optical multimodality imaging technique is to combine OCT and 
fluorescence laminar optical tomography (FLOT) to simultaneously acquire 
morphological and molecular information from a biological sample with a depth 
resolution of a couple millimeters. FLOT uses a photodetector array to detect back-
scattered light away from a scanning spot with different pathways. A depth-resolved 
image is reconstructed from the detected signals utilizing a mathematical algorithm such 
as a radiative transport equation based on a Monte-Carlo simulation [125, 126].  
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Figure 14: In-vivo co-registered OCT and FLIM images of SCC with hamster check pouch model. (a) 
OCT 3-D volume shows a thick middle region surrounded by thinner tissue. (b) and (c) sample OCT 
cross-sectional image and corresponding histology. (d) FLIM images showed two distinct regions: a center 
area with a fluorescence that is characteristic of nicotinamide adenine dinucleotide (NADH) and flavin 
adenine dinucleotide (FAD), and a surrounding area with an emission that is characteristic of collagen. 
Tumor area (tumor (T), scale bar = 300 µm, and field of view: 2 x 2 mm2). Reprinted with permission 
from [120]. 
 
Figure 14 shows OCT/FLOT images of a human breast cancer xenograft model in vivo. 
In the OCT image (a), the layers of skin are not clear due to the similar scattering, but 
the boundary between the skin and tumor is clearly visible. The co-registered FLOT 
image (b) indicates the subcutaneous tumor. The fused OCT/FLOT image (c) 
demonstrates the position, distribution and size of the tumor located underneath skin, 
and is confirmed with corresponding histology (d) [126]. 
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The combination of OCT and Raman spectroscopy (RS) is also capable of 
providing structural and molecular information from complex tissue samples. Despite 
the long integration times ranging from approximately 3 to 30 seconds and low quality 
structural information, near-infrared RS techniques have the advantage of high 
molecular specificity which can be an asset for detecting cancers [127, 128]. The 
combination with OCT can compensate for some of the drawbacks by providing optical 
sectioned tomographic images with micron scale resolution. Figure 15 displays an OCT 
cross-sectional image of ex vivo malignant human breast tissue using an OCT/RS 
system. Normal and abnormal regions with high-density scattering signals were noted in 
the OCT cross-sectional image of Figure 15(a). Using the OCT as a guide, RS signal was 
collected from the areas of interest. Figure 15(b) shows the Raman spectra from the two 
areas identified as normal and malignant. The Raman spectrum of the normal area was 
dominated by signals consistent with the presence of lipids. However, the malignant 
region had showed a higher contribution from DNA and proteins, especially collagen 
[127]. 
Development of multimodal OCT systems can clearly profit by tapping into the 
wealth of research that has gone into the modality that it is being paired with. In the case 
of fluorescence and Raman spectroscopy there has been considerable research related to 
cancer diagnosis [129, 130]. Nevertheless, the ensuing technology tends to be much 
more complex and requires compromises related to the typical mismatch between 
imaging speed, resolution, and/or dimensionality of the image (e.g. 2-D v. 3-D).  
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Figure 15: OCT Image and Raman shift of ex-vivo malignant human breast tissue from OCT/RS system. 
(a) OCT cross-sectional image, normal region of tissue (solid line), malignant region of tissue (dashed 
line) (b) Intensity of Raman shift signal from the (a), scalebar = 500 µm. Reprinted with permission from 
[127]. 
 
2.6 Pump-Probe OCT 
2.6.1 Theory of pump-probe OCT 
Pump-Probe optical coherence tomography (PPOCT) integrates OCT with the 
pump-probe spectroscopy to provide molecular contrast. The pump-probe technique has 
been widely employed in experimental molecular physics to measure excited electronic 
states and molecular dynamics. Nominally, in pump-probe spectroscopy, when a 
molecule absorbs the energy of a pump photon, an electron is promoted into an excited 
state. The measurements of subsequent probe photon interactions with the molecule 
reveals how the excited state evolves over time. Both the intensity of the pump-probe 
interaction and the time evolution of the signal measured by varying the delay between 
the pump and the probe are unique molecular properties that may be used to distinguish 
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among different molecules. In practice, given the complexity of both the molecules of 
interest and their tissue environment it is unlikely that the simple mechanism noted 
above can hold in its entirety. Fundamentally, any mechanism that leads to a change in 
the probe intensity after interaction with the pump will generate PPOCT signal. 
 
 
Figure 16: A schematic diagram of PPOCT. Pump light source: Q-switched 532nm laser, Probe light 
source: SLD or Ti:Sapphire laser at 830nm center wavelength, L: lens, NDF: neutral density filter, DM: 
dichroic mirror, M: mirror, DG: diffraction grating, LSC: line-scanning camera. Reprinted from [131]. 
 
PPOCT may be accomplished by integrating a pump laser into the sample arm of 
an existing OCT system. The light source for the OCT system may then serve as the 
probe beam. The pump source needs to be selected based upon the molecular properties 
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of the target molecule. The co-propagating pump and probe beams excite the sample. A 
typical setup for PPOCT is shown in Figure 16. By modulating the pump beam with 
frequency, fm, the pump-probe interaction can be monitored by scanning the sample over 
time. The frequency response of a time domain PPOCT system can be expressed as the 
carrier frequency of the reference arm plus or minus fm [91] . In a spectral-domain OCT 
system, the pump-probe signal can be filtered out from an OCT M-scan (line images 
measured as a function of time instead of space). The PPOCT signal from spectral 
domain OCT may be extracted at the fm following a Fourier transform along the time 
axis of an M-scan. A flow chart of this process is shown in Figure 17. 
 
 
Figure 17: Flowchart of data collection and processing of PPOCT. An M-scan of OCT is collected and a 
Fourier transform is taken at every depth. The modulation frequency is extracted at each depth to compile 
the PPOCT A-line. 
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2.6.2 Applications of pump-probe OCT 
In principle, any molecule that absorbs light can be used as an exogenous 
contrast agent for PPOCT, including fluorescent dyes and proteins. Indocyanine green 
[133], dsRed [132], and methylene blue [134] have all been shown to provide contrast 
via PPOCT. In the initial PPOCT experiments, Rao and coworkers [134] demonstrated 
the ability to monitor the pump-probe interactions of methylene blue using a 532 nm 
pump and 800 nm probe. Following up this work, Applegate et al. [131] developed a 
degenerate PPOCT system with a pump and probe at 532 nm and used it to image the 
distribution of the fluorescent protein dsRed in the skeletal muscle of transgenic 
zebrafish. Some results from this study are shown in Figure 18. Images were recorded 
from two areas of the zebrafish indicated by the boxes in Fig 18(a). OCT images and 
overlays of the PPOCT onto the OCT images are shown in Figure 18(b), (c), (e), and (f). 
Figure 18(d) and (g) show the overlay of the derivative of the PPOCT signal onto the 
OCT image. The derivative was calculated to take into account the fact that light 
absorption is integrated in depth, in other words light can be absorbed along the entire 
path the light travels, not just where the light is backscattered.  
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Figure 18: A) Photo of transgenic zebra danio fish expressing dsRed in its skeletal muscle. B) OCT cross-
section recorded through the back of the fish, anterior to the dorsal fin as indicated by the top white box in 
the photo. C) Overlay of the corresponding ground state recovery PPOCT (gsrPPOCT) image onto the 
OCT image in B. The color bar indicates the SNR of the gsrPPOCT signal (max 47 dB). D) Derivative 
image derived from panel C. E, F, G) Same as B, C, and D except recorded along a cross-section (bottom 
white box) bisecting the pectoral fin (PF) and continuing into the lateral line (LL). The maximum recorded 
SNR gsrPPOCT in panel E was 37 dB. The scale box is 200 µm×200 µm. Reprinted from [132] 
 
Several endogenous chromophores have also been probed with PPOCT. Previous 
studies have demonstrated melanin [135, 136], Phytochrome A [137], and hemoglobin 
[131] imaging via PPOCT. 
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3. DEVELOPMENT OF PPOCT SYSTEM* 
 
This chapter describes the design and development of the PPOCT system, and 
provides experimental ex/in vivo results. As an initial test, performance of PPOCT 
system was demonstrated with a capillary tube model as detailed in the section of 
Results. Also, the PPOCT system was validated for its ability to acquire morphology and 
molecular contrast-enhanced signal from endogenous (Hb) or exogenous (MB) agent 
simultaneously from the experiments on the live animal.  
3.1 Imaging in Xenopus laevis 
3.1.1 Method 
The schematic of the two-color Fourier-domain PPOCT system is illustrated in 
Figure 16. Two different near-infrared sources were utilized as the probe/ OCT beam. 
The first was a tunable 140fs Ti:Sapphire laser operated at 830nm. The Ti:Sapphire was 
spectrally broadened to ~200 nm bandwidth. The SLD with a center wavelength of 830 
nm and a bandwidth of 40 nm was utilized as the second probe source. The SLD allowed 
for greater power on the sample and offered better intensity stability than the 
Ti:Sapphire. The powers of the pump and probe sources are stated for each individual 
experiment be- low. The probe source was launched into a 2×2 (50:50) fiber coupler. 
                                                
* Reprinted with permission from [131] Carrasco- Zevallos, Oscar, Ryan L. Shelton, Wihan Kim, Jeremy 
Pearson, and Brian E. Applegate. "In vivo pump- probe optical coherence tomography imaging in 
Xenopus laevis." Journal of biophotonics 8, no. 1-2 (2015): 25-35 
[138] Kim, Wihan, and Brian E. Applegate. "In vivo molecular contrast OCT imaging of methylene blue." 
Optics letters 40, no. 7 (2015): 1426-1429. 
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Galvanometer mirrors were used to laterally scan the OCT beam over the sample, while 
a mirror positioned in the referenced arm completed the Michelson interferometer. The 
pump source consisted of an actively Q-switched Nd:YVO4 laser, frequency doubled to 
532 with a maximum pulse repetition rate of 100 kHz. Co-propagation of pump and 
probe beams at the sample was achieved using a dichroic mirror. A custom spectrometer 
employing a linescan camera with a maximum line rate of 53 kHz completed the FD-
OCT system.  
When precise control of interpulse delay was required, the Ti:Sapphire was 
utilized as the probe and the Q-switched pump was triggered by a sync pulse from the 
Ti:Sapphire pulse picker, which enabled temporal synchronization of both lasers. The 
sync pulse was passed through a digital delay generator (Hiland Technology, P-400) to 
allow control of the interpulse delay. The sync pulse of the Ti:Sapphire was also used to 
trigger the linescan camera to capture the back-reflected spectra. A camera integration 
time of 20 ms was used, which limited the repetition rate to 40 kHz. In order to encode 
the transient absorption into the OCT signal, a 15 kHz square wave modulation was used 
to time-gate the Q-switch output and amplitude modulate the pump source. Conventional 
OCT processing methods were utilized to acquire an OCT M-scan. The pump-modulated 
PPOCT information was extracted by performing a Fourier transform of the M-scan 
along the time dimension and subsequently filtering around the modulation frequency at 
each depth, yielding a PPOCT A-line. Therefore, an OCT M-scan corresponds to a 
PPOCT A-line. Similarly, a PPOCT B-scan can be obtained from a 2-D OCT M-scan. 
This processing technique is outlined in more detail in [135].  
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The imaging speed of the system is governed by the OCT line rate and the 
number of OCT A-lines (M-scan) used to produce a PPOCT A-line. Due to the PPOCT 
processing algorithm, reducing the number of OCT A-lines yields faster PPOCT 
imaging rates, but reduces PPOCT SNR. The number of OCT A-lines used to generate 
each PPOCT A-line in Figures 4 and 5 was 300 resulting in an effective line rate of 133 
Hz. For Figures 3 and 6, 100 a-lines were used for an effective line rate of 400 Hz. 
Previous work characterized the speed and SNR relationship of a similar Fourier-domain 
PPOCT system [135].  
Pump power also contributes to PPOCT SNR. While higher pump power could 
be used to achieve better signal quality, the safety of the specimen being imaged needs 
to be taken into account. For the in vivo experiments in this study, the surface fluence 
was kept below the ANSI safety limits for skin. 
Finally, we should note that PPOCT inherently measures the attenuation of light 
due to absorption. Absorption of light is integratived over its path- length, hence the 
PPOCT signal is inherently dependent on the pathlength through the sample. Similarly, 
since the attenuation is reported by light that is back-reflected from the sample, the 
signal is dependent on the sample reflectivity and the location in the sample where it was 
reflected. [139] In other words, probe light incident on the sample that passes through 
the chromophore will be attenuated and modulated by the pump interaction with the 
chromophore. This light can be back-reflected at the chromophore or somewhere deeper. 
The light reflected at the chromophore accurately reports the attenuation and position of 
the chromophore. However, light reflected deeper than the chromophore accurately 
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reports the attenuation, but not the chromophores location. This effect will be obvious in 
the images of capillary tubes shown below (Figure 20) where a PPOCT signal is 
observed at the bottom surface of the capillary tube but not the top. As we have 
discussed previously [132] this ambiguity may be lifted by normalizing to the 
reflectivity measured in the OCT image and calculating the derivative after smoothing to 
reduce speckle.  
For the images shown below, we have not taken this additional processing step. 
Blood is a strong absorber and scatterer, hence the majority of the PPOCT signal is at the 
position of the blood vessel. In our previous work with imaging blood we only noted a 
modest improvement by calculating the derivative image but with a substantial sacrifice 
of resolution.  
3.1.2 Results 
3.1.2.1 PPOCT system characterization 
We have investigated the lifetime characteristics of the PPOCT signal from both 
MB and hemoglobin with a 532 nm pump and an 830 nm probe. MB serves as an 
archetypal molecule where the photo- physics are well known. Hemoglobin, on the other 
hand, is a complex heme protein with photophysics that are not well understood. This 
leads to some ambiguity in the origin of the hemoglobin PPOCT signal. 
The performance of the system was evaluated by measuring the PPOCT signal 
from a 0.05% solution of MB between two coverslips. The average power of the pump 
and probe beams were 17 mW and 160 mW (100 kHz repetition rate), respectively. 
Recording the PPOCT signal as a function of the pump-probe interpulse delay enabled 
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the measurement of the triplet state dynamics. The strongest PPOCT signal arises from 
the top surface of the bot- tom coverslip with this sample. The peak of that signal is 
plotted as a function of interpulse delay in Figure 19(A) while Figure 19(B) depicts the 
pump-probe process exploited for MB PPOCT imaging.  
 
 
Figure 19: (A) Molecular energy level diagram for the methylene blue PPOCT mechanism. Driven 
transitions are indicated by straight arrows and spontaneous transitions as wavy arrows. (B) Measured 
normalized decay (blue cir- cles) and exponential fit of the PPOCT signal due to methylene blue as a 
function of delay between the pump and probe pulse. The decay has a fit lifetime of 297 ns and a 
characteristic average lifetime of 247 ns.  
 
The resulting temporal decay was fit to a single exponential curve. The inverse of 
the decay constant is the lifetime of the T1 state or τAB*  assuming the intersystem 
crossing is very fast and τ*B*  is therefore negligible. A lifetime of 297± 17 ns was 
measured, where the quoted error is the 95% confidence interval from a fit of 25 data 
points collected at 100 ns intervals. The MB triplet state is readily quenched by oxygen, 
hence the exact lifetime is a function of the oxygen level in the MB solution and varies 
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from less than 0.3 us to 79.5 us [140]. A highly oxygenated state is expected since no 
effort was made to deoxygenate the solution. However, the measured lifetime is lower 
than one would expect given a MB solution stored in air and likely contains some 
contribution from photobleaching. Nevertheless, this result demonstrates the system’s 
ability to measure the temporal decay of the pump-probe signal with increasing 
interpulse delay. 
The average lifetime (𝜏EFG = 𝑠 ∙ 𝑡/ 𝑠) is much faster and easier to calculate 
than an exponential fit. Moreover, it is more reliable for noisy data. The calculated 
average lifetime for the decay in Figure 19(B) is 247 ns, somewhat lower than given by 
the fit, but still reasonable. The average lifetime is more practical for high-speed imaging 
and may prove useful in the future for differentiating chromophores based on their 
lifetime characteristics. 
Since 532 nm and 830 nm pump-probe imaging of Hb has not previously been 
demonstrated, we sought to characterize the lifetime dynamics of the Hb signal for the 
first time. Time resolving the PPOCT signal from Hb yielded a somewhat unexpected 
result. While there is clearly a variation in the Hb signal on the time scale of the 15 kHz 
modulation (66 us) there was no apparent change in the signal when we varied the delay 
over the entire 25 us period (40 kHz) between pulses. Given the fairly strong intensity 
noise due to spectral broadening of the Ti:Sapphire pulses in the single mode fiber, we 
would estimate the accuracy of our measurement to ±5%. Nevertheless, that would seem 
to indicate that we are exciting the Hb into some long- lived state. A literature search 
yielded two mechanisms that would explain our observations. The first is that photo-
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initiated oxidation of þ Fe+2 into Fe+3 in the heme protein via the 532 nm pump results in 
the formation of methemoglobin (metHb) [141]. MetHb has a factor of 2–3 larger 
absorption coefficient than oxy- and deoxy-Hb in the NIR [142]. Since metHb is only 
slowly enzymatically [143] converted back to Hb, each time the pump interacts with the 
blood sample the concentration of metHb increases stepwise. The frequency spectrum of 
a stepwise increasing function has a strong component at the step frequency, hence 
modulation of the pump intensity leads to a modulation in the nearIR absorption that 
would be observed in the probe. 
The second mechanism involves the population of high lying vibrational states in 
the ground state of oxy- and deoxy-Hb which will effectively red-shift the absorption 
spectrum [144] leading to a relative change in the nearIR absorption. The high lying 
vibrational states are populated via internal conversion of the excited electronic state 
which has been populated by the 532 nm radiation. This creates “hot bands” in the 
hemoglobin spectrum that leads to the red-shift. This can be thought of as local heating 
which shifts the Boltzmann distribution thereby populating higher vibrational states in 
the ground electronic state. The net result is that a modulation of the pump power leads 
to a modulation in the nearIR absorption that would be observed in the probe and have a 
long lifetime. 
It seems likely given the results in the literature that both mechanisms play some 
role. Our current hypothesis is that the first mechanism (metHb) is more important at 
high power and long dwell times and the second mechanism is more important at lower 
powers and short dwell times. This hypothesis is based in part on our observation of the 
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formation of solids in capillary flow tubes with high pump powers and with low pump 
powers on samples with no flow after long exposure times. The formation of solids was 
accompanied by strong PPOCT signals. These observations are consistent with the prior 
mechanistic studies of photocoagulation that showed significant concentrations of 
metHb at the onset of coagulant formation [142]. Taking into consideration light 
scattering and the relatively low powers used for in vivo imaging in this work, the 
second mechanism most probably is the primary contributor to the PPOCT signal for in 
vivo imaging.  
Establishing a more clear understanding of the photophysics at play will be key 
to moving forward and developing techniques for oxygen saturation measurement. In the 
first mechanism, formation of metHb is believed to primarily follow from oxy-Hb. The 
lack of sensitivity to deoxy-Hb would complicate any algorithm designed to measure 
oxygen saturation. The second mechanism on the other hand would occur in both oxy- 
and deoxy-Hb and likely change the NIR absorption in different ways. This mechanism 
would lend itself to a more straightforward algorithm development.  
We should also note that there may be some contribution simply from the 
thermal heating of the sample leading to movement of the scatters. Both mechanisms 
involve heating of the sample. This type of contrast has been observed previously with 
gold nanoparticles [70, 145] as well as blood [146]. In these works, thermal heating 
leads to submicron movement of the scatterers that is detected in the interferometric 
phase by phase-sensitive OCT. In our PPOCT experiments we measure the modulation 
of the inter- ferometric amplitude, not the phase. While there is undoubtedly some 
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modulation of the phase as well, the scatterer motion should be well below the resolution 
of the OCT system and therefore only make a very minor contribution to the signal, if 
any. Additionally, we would expect a strong signal in the interferometric phase at the 
modulation frequency if the signal were due to thermally induced movements of the 
scatters. We only measure a very weak phase signal when the amplitude signal is quite 
strong. Finally, the PPOCT images of the blood filled capillary tube in Figure 20 shows 
signal at the bottom surface of the capillary tube but not the top. This is a well-known 
artifact associated with PPOCT (discussed above) that should not be present if the 
contrast were due to thermally induced movement of the blood.  
3.1.2.2 Time resolved PPOCT for molecular specificity 
The vastly different excited state dynamics of Methylene Blue and hemoglobin 
allow the two chromophores to be differentiated by observing PPOCT signals from two 
different interpulse delays: one immediately after the pump, where the transient 
absorption should be greatest, and one long after the excited triplet state of the 
Methylene Blue has relaxed down to the ground state. The current PPOCT system can 
image Methylene Blue and hemoglobin simultaneously and subsequently separate the 
two signals based on ground state recovery time. 
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Figure 20: (A) OCT B-scan of Methtylene Blue (MB) and hemoglobin (Hb) in acrylic capillary tube (B) 
Corrrespoding PPOCT B-scan with a pump/probe delay of 3 ns. (C) Corresponding PPOCT B-scan with a 
pump/probe delay of 24.8us  
 
In order to verify this assertion, two capillary tubes (200mm inner diameter), one filled 
with bovine whole blood and the other filled with Methylene Blue, mixed with 
polystyrene beads to provide scattering contrast, were imaged with the PPOCT sys- tem. 
The pulse picker of the Ti:Sapphire laser was synchronized with both the trigger input of 
the Nd:YVO4 and the linescan camera of the spectrometer. The power at the sample of 
the Ti:Sapphire and the Nd:YVO4 were kept constant at 90 mW and 15 mW, 
respectively. Both probe and pump were operated at a repetition rate of 40 kHz. As 
shown in Figure 20, PPOCT B-scans of the capillary tubes containing Methylene Blue 
and hemoglobin were obtained. Figure 20(A) depicts a conventional OCT B- scan of the 
capillary tubes. Figure 20(B) depicts a PPOCT B-scan obtained with a pump/probe delay 
of 3 ns, thus ensuring optimal PPOCT signal from methylene blue. Figure 20(C) shows a 
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PPOCT B-scan taken at an interpulse delay of 24.8 us, ensuring that the probe irradiation 
occurs well after the 297 ns ground state recovery time of the triplet state. As expected, 
this results in no PPOCT signal from Methylene Blue in Figure 20(C). In contrast to 
Methylene Blue, hemoglobin’s long-lived state populated by the pump allows absorption 
of the probe even at an interpulse delay of 24.8 us. A PPOCT B-scan obtained with the 
pump blocked was used for back- ground subtraction from each PPOCT image.  
It is important to note, that the specular reflection from the top of the capillary 
tubes only show up in the OCT image, while the specular reflection from the bottom of 
the capillary tubes show up in all images. This is consistent with expectations as 
explained in [135], since only surfaces after an absorption event will carry signal due to 
transient absorption.  
This experiment illustrated the first time separation of different chromophores 
via lifetime with PPOCT. The extreme difference in the dynamics of MB and Hb 
enabled the use of only two time points to distinguish them. As the dynamics of the 
chromophores become more similar it will be necessary to use more sophisticated 
techniques such as fitting the temporal decay or calculating the average lifetime as 
shown for MB above. Furthermore, differentiation of chromophores via lifetime may 
prove important when the chromophores of interest exhibit overlap- ping absorption 
spectra. If the absorption bands of the chromophores are sufficiently distinct, then 
techniques such as spectroscopic OCT could be used to differentiate the chromophores 
based on absorption. However, spectroscopic OCT suffers from an inherent tradeoff 
between depth resolution and spectral resolution. If high spectral resolution is required to 
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separate the chromophores, knowledge of their depth location is sacrificed. Therefore, 
differentiation of chromophores via lifetime, as demonstrated in this work, may prove 
important when the chromophores of interest exhibit overlapping absorption spectra.  
3.1.2.3 in vivo PPOCT imaging 
To demonstrate the first in vivo PPOCT images of Xenopus tadpole vasculature, 
the SLD was used as the probe, which offered better stability and offered higher power 
than the pulse-picked Ti:Sapph laser. The probe and pump powers were kept constant at 
1.2 mW and 10 mW respectively. Live Xenopus tad- poles were anesthetized according 
to the animal use protocol overseen by the Institutional Animal Care and Use Committee 
at Texas A & M University and imaged with the PPOCT system. Figure 4 depicts three 
OCT B-scans overlayed with the intrinsically co-registered, thresholded PPOCT B-
scans. The tadpole vasculature is clearly identified via the PPOCT overlay. It is 
interesting to note that several capillaries (denoted by arrows), which were not 
identifiable in the conventional OCT B-scan, are easily identified by the added PPOCT 
molecular contrast.  
We have previously explored the sensitivity of PPOCT both theoretically [139, 
132] and experimentally [135, 132]. When imaging melanin with a nearIR pump and 
probe, we were able to measure PPOCT signals at the full depth of the OCT image. In 
these experiments we do not have the same control over the sample; however, we can 
compare signals from vessels measured at various depths to get a qualitative feeling for 
the sensitivity and potential imaging depth. In a cross-sectional image similar to one 
shown in Figure 21(A) (nearby in the volume stack) we identified 3 nearly equally 
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spaced vessels. The vessels were at a depth of 0 mm, 223 mm, and 450 mm. On an SNR 
scale the signal from each was 31 dB, 28 dB, and 23 dB, respectively. The two deepest 
vessels were capillary sized while the surface vessel was larger. Assuming homogenous 
tissue with a constant scattering coefficient the signal should decay approximately 
linearly with depth when viewed on a log scale. A linear fit predicts an SNR of 14 dB at 
the full depth of the OCT image which was ~950 mm. Under these experimental 
conditions we should be able to observe PPOCT signal from blood up to the full imaging 
depth in this sample. Of course it is al- ways possible to trade time (number of A-lines 
used) for signal in order to improve SNR.  
The B-scans in Figure 21 clearly illustrate that PPOCT can be used to 
discriminate vasculature in vivo. As previously discussed, there are also well known 
extensions of OCT that can accomplish the same task while also supplying information 
related to blood flow velocity, DOCT, pvOCT and speckle variance OCT techniques. 
However, if the flow is orthogonal to the optical axis, the Doppler shift is exactly zero 
and the DOCT and pvOCT signals will also be zero. This issue is prominent if the path 
of the vasculature becomes tortuous, in which case the flow changes direction frequently 
and abruptly lead- ing to nodes in the DOCT and pvOCT images. These vessel 
discontinuities must be restored in order to properly map the vascular network. 
 56 
 
 
 
Figure 21: (A), (B), and (C) are PPOCT B-scans overlaid on the corresponding co-registered OCT B-
scans. X. laevis vasculature are clearly depicted. Arrows in (A) point to capillaries that were not visible in 
conventional OCT. Scale bar is 100 mm.  
  
The B-scans in Figure 21 clearly illustrate that PPOCT can be used to 
discriminate vasculature in vivo. As previously discussed, there are also well known 
orthogonal to the optical axis, the Doppler shift is exactly zero and the DOCT and 
pvOCT signals will also be zero. This issue is prominent if the path of the vasculature 
becomes tortuous, in which case the flow changes direction frequently and abruptly 
leading to nodes in the DOCT and pvOCT images. These vessel discontinuities must be 
restored in order to properly map the vascular network.  
To illustrate this point, a volumetric PPOCT image of a tortuous vessel in an 
anesthesized Xenopus tadpole was acquired. Conventional DOCT and pvOCT post 
processing was performed on the same data set, since, the data required for Doppler and 
phase-variance processing is already acquired for PPOCT imaging. To ensure that the 
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discontinuities in the DOCT and pvOCT images were not just due to low SNR at random 
image location, but rather due to low SNR at and around the nodes, we implemented 
spatial averaging to improve the SNR of the image. The same processing was also 
applied to the PPOCT images to facilitate comparison. We should note that far more 
OCT a-lines were used to calculate the DOCT image than are typically used which 
further improved the SNR over what is typically found in the literature. The averaging 
was performed as follows. The vol- umetric image was convolved in three-dimensions 
with a weighting function in which the weights were calculated as one divided by the 
pixel distance from the center pixel, including all pixels up to 2 from the center. For the 
purpose of calculating the weighted average of the pixels near the perimeter of the 
volume, the pixels outside the volume boundary were assumed to have a pixel value 
equal to the nearest known pixel value.  
Figure 22 depicts an OCT volume (A) and two B-scans (B, C) depicting cross-
sectional images of blood vessels. (D – G) are cross-sectional cuts along the yellow lines 
depicted in (B) and (C). The OCT, pvOCT, DOCT, and PPOCT images are depicted in 
(D), (E), (F), and (G), respectively. As discussed above, vasculature contrast in pvOCT 
and DOCT may result in nodes when imaging tortuous vessels. Because of its inherent 
molecular contrast, PPOCT is not sensitive to directionality of flow. This fact is 
evidenced in Figure 22(G), in which the entire vessel structure is clearly demarcated by 
the additional PPOCT contrast. Note that sharp changes in flow directionality do not 
degrade the PPOCT signal, in contrast to the pvOCT and DOCT images where nodes are 
clearly visible. From these results it appears PPOCT contrast may be more desirable than 
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DOCT or pvOCT when imaging tortuous vasculature. In addition, since pvOCT and 
DOCT processing can be performed on PPOCT data, any flow velocity information not 
inherent to PPOCT contrast can be obtained in post-processing.  
Speckle variance techniques for imaging flow with OCT can also accurately 
reproduce the vasculature even when the flow is orthogonal to the illumination.  
 
  
Figure 22: Volumetric OCT image of tadpole. (B) Cross-sectional image in the x, z plane. (C) Cross-
sectional image in the y, z plane. D–G are cross-sectional images along the plane defined by the yellow 
lines in (B) and (C). (D) OCT image (E) OCT image overlaid with the phase variance signal indicating 
blood flow (F) OCT image overlaid with the Doppler Signal blood flow and direction. (G) OCT image 
overlaid with the pump-probe signal from blood. Note the continuity in the vessel indicated by the PPOCT 
image in this tortuous blood vessel. The tortuosity results in a large number of direction changes and 
therefore nodes in both the Doppler and phase variance images.  
 
Speckle variance techniques for imaging flow with OCT can also accurately 
reproduce the vasculature even when the flow is orthogonal to the illumination. However 
the imaging speed for these techniques are fundamentally tied to the speckle 
decorrelation time which can be milliseconds [147, 148] for slow flowing blood like that 
 59 
 
found in capillary beds. Consequently, improving the imaging speed of the OCT system 
by for instance using a linescan camera with shorter read time and therefore higher line 
rates will not improve the imaging speed of speckle variance techniques in the same way 
it would for PPOCT. 
Neovascularization and angiogenesis in malignant tumors typically leads to 
tortuous and leaky vascular networks. According to [149], “blood vessels of tumors are a 
messchaotic, leaky, inefficient, and barely making do.” OCT and its functional 
derivatives have been used extensively as a tool for understanding tumor growth 
including neovascularization and angiogenesis [150]. PPOCT imaging of hemoglo- bin 
can augment this set of tools to provide a more complete vascular map. It may also be 
able to provide some insight into leaky vasculature if erythrocytes are leaked to the 
surrounding tissue. 
Many cancer studies are initiated for, or involve the imaging of excised tissue 
either from tissue biopsies or from excised tumors. In these cases, OCT techniques 
which require flow for mapping vasculature obviously fail. However, since PPOCT 
imaging of vas- culature only requires the presence of hemoglobin, it may be used as a 
tool to grade the extent of neovascularization and angiogenesis in excised tissues. 
An ex vivo image of the vasculature in a euthanized Xenopus tadpole is shown in 
Figure 23. These two views of a volumetric PPOCT dataset show several vessels 
including a bifurcation. Qualitatively, the signal strength from non-flowing blood is 
stronger than for flowing blood. This may be due the generation of metHb in coagulated 
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blood, hence engaging the first of the mechanisms for PPOCT signal gen- eration 
discussed above. 
 
 
Figure 23: Two views of a volumetric reconstruction of the PPOCT data recorded on a euthanized 
Xenopus tadpole. The volume is 2mm 2mm 1mm. The lines in the low- er left and right edges of the 
images are artifacts.  
 
PPOCT is directly measuring absorption in the molecule of interest, which 
suggests this technique could be used to measure blood oxygen saturation (SO2), a key 
parameter for early indication of many pathological conditions. PPOCT for retinal 
imaging may enable vasculature demarcation with simultaneous SO2 measurements. 
The complementary struc- tural and functional information provided via PPOCT may 
enable more accurate tracking of ocular diseases. The current standard for functional 
retinal imaging is a multi-color Scanning Laser Ophthalmoscope (SLO). However, SLO 
images are restricted to an en face view of the fundus due to its confocal gating de- 
tection scheme. Therefore, SO2 measurements and other functional parameters can only 
be extracted from the surface of the fundus. However, the retinal microvasculature is a 
complicated, three-dimensional network that extends through the different retinal sub-
surface layers. As is well recognized, OCT coher- ence gating enables micron-scale, 
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depth-resolved structural mappings of retinal layers. The additional molecular contrast 
provided by PPOCT could enable depth-resolved functional measurements of the entire 
retinal microvasculature, rather than solely surface vessels.  
3.2 Imaging in larval stage of Zebrafish treated with MB 
3.2.1 Method 
As an initial step, we took a fresh look at the choice of pump laser sources. 
Recognizing the inefficiency of the 532 nm excitation, we looked to laser sources that 
could excite near the 660 nm peak where the absorption cross-section is a factor of 20 
larger. Pulsed lasers with 10–100 kHz repetition rates at that wavelength are uncommon, 
hence we turned to continuous-wave (cw) diode lasers that could be amplitude 
modulated. Such lasers are inexpensive, robust, and readily available. In this regime, 
where there is no longer short-pulse laser ex- citation, the timing between the pump and 
probe pulse is obviated, thus enabling the use of cw probes, such as a superluminescent 
diode. Since the probe is the OCT light source, this paradigm shift enabled PPOCT 
imaging of MB with only minor modifications to an 830 nm band spectral-domain OCT 
system.  
The losses due to transient absorption can be modeled as a reduction in the 
sample reflectivity (𝑅L), where the OCT signal is proportional to 𝑅L* M = 𝑟L. In the case 
of absorption due the triplet state of MB the reflectivity becomes 𝑟L,A 1 − 𝜎)𝑁)𝑑𝑧  
where 𝜎)is the triplet state absorption cross-section, 𝑁)is the triplet state population, 𝑑𝑧 
is the pathlength, and we have assumed the weak absorption limit where the exponential 
function can be approximated by the first two terms of its Taylor series expansion. Prior 
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to interacting with the pump laser, 𝑁) is exactly zero. If we assume an impulse pump 
excitation, then 𝑁)  is populated by intersystem crossing from 𝑆*  with a quantum 
efficiency of q and immediately begins to decay, yielding 𝑁) = 𝑞𝑁T*𝑒BV W where τ-1 is 
the decay rate back to the ground state and the decay is assumed to be a single 
exponential. This approximation holds for short pulsed pump lasers as in our previous 
work. [131] There we were able to measure 𝜏 for MB by varying the interpulse delay 
between the pump and probe to map out the decay and fit to a single exponential. In the 
case of a sine modulated pump laser (i.e. XYZ[ 1 + 𝑠𝑖𝑛	 𝜔𝑡 ) we must explicitly consider 
the time dependent population of 𝑁T* . Under these circumstances the triplet state 
population is proportional to the convolution, 𝑁) ∝ 1 + 𝑠𝑖𝑛(𝜔𝑡) ⨂𝑒BV W . Evaluating 
the convolution yields, 𝑁) ∝ 1 + 1 + 𝜔M𝜏M B* M .where 𝜙 = 𝑡𝑎𝑛B* 𝜔𝜏 . Inserting a 
proportionality constant, β, to account for the efficiency with which the singlet excited 
(𝑆*) state is populated as well as folding in the quantum efficiency (𝑞), the absorption 
cross-section ( 𝜎) ) and a factor of 0.5 we can rewrite the reflectivity as 𝑟L ≈𝑟L,A 1 − 𝑑𝑧𝑃de𝛽 1 + 1 + 𝜔M𝜏M B* M 𝑠𝑖𝑛 𝜔𝑡 − 𝜙 . Here we can see that the transient 
absorption signal will be sine modulated at the same frequency as the pump modulation 
with a phase shift of ϕ and scaled by 1 + 𝜔M𝜏M B* M. The phase shift and scaling are 
both dependent on the product of the modulation frequency and triplet state lifetime. 
This result is exactly analogous to frequency domain fluorescence lifetime microscopy 
where the phase of the signal is used to measure fluorescence lifetimes. [151] In our case 
the phase can be used to determine the triplet state lifetime. 
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Figure 24: (a) Simplified energy level diagram for methylene blue. (b) PPOCT system schematic. Pump 
source, modulated 663-nm diode laser; probe source, SLD at 830-nm center wavelength; DM, dichroic 
mirror; RM, reference arm mirror; GM, galvanom- eter scanner; OBJ, objective lens.  
 
The modified OCT system used for this study is shown schematically in Figure 
1b. A superluminescent diode with ~40 nm bandwidth centered at 830 nm was used as 
the OCT light source. The pump source was a 663 nm diode laser (Toptica, iBeam Smart 
PT660) with a maximum output of 60 mW. The output of the diode laser could be sine 
modulated and/or pulsed. The 830 nm light was launched into a 2x2 fused fiber coupler 
that formed a Michelson interferometer. The 830 nm light in the sample arm also 
constitutes the probe. The pump beam was directed into the sample arm via a dichroic 
mirror. The pump and probe were focused at the same position to a spot diameter of ~19 
µm and laterally scanned on the sample by a galvo mirror pair.. The signal due to the 
absorption of the pump was frequency encoded by modulation of the pump at 14 kHz in 
all cases. The detector was a custom spectrometer operated with a line rate of 40 kHz 
and 8 µs integration time.  The spectral interferograms were processed in the typical way 
to generate OCT M-scans. The PPOCT signal was extracted from an M-scan via Fourier 
transform along the time axis and filtered as described previously [135].  
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3.2.2 Results 
Initially we conducted a simple experiment on a phantom to validate a new background 
subtraction method.  The background arises from amplitude noise on the light source 
that decays approximately as 1/f. The phantom was a 200 µm inner diameter plastic 
capillary tube containing a flowing solution of 2% MB mixed with titanium oxide 
(Sigma-aldrich). The pump power was 4.4 mW and the probe was 1.4 mW. The tube 
was positioned at an angle to avoid the strong specular reflection from the tube surface. 
Figure 2a is the power spectrum at one depth in a PPOCT A-line of the phantom. The 
peak at 14 kHz (pump on) is the PPOCT signal. When the pump is off the PPOCT signal 
is gone, but the noise remains. As a result, there is a strong background signal which if 
left uncorrected could complicate the interpretation of PPOCT images. In order to 
mitigate this problem, we used a background normalization method to remove signal 
background due to source intensity noise at the pump modulation frequency. The 
background level at frequencies above and below (±2 kHz) the pump modulation 
frequency were measured and averaged. The implicit assumption is that the background 
is well represented by a linear function over this small frequency range. The PPOCT 
signal was divided by the average noise background level, hence the mean of the noise 
background is 1. The normalized PPOCT signal was then thresholded to remove all of 
the noise background. We found that a threshold of 2.5 was sufficient to completely 
remove the background seen in the images of the phantom, Figure 25(b). This algorithm 
could be done on each pixel in the PPOCT image to enable essentially real-time 
measurement and removal of the background. 
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Figure 25: (a) Frequency domain signal from one pixel in the MB filled capillary tube with and without 
the pump on. The relevant aspects of the background subtraction algorithm are labeled where the 
background is assumed to vary linearly over a nar- row frequency range. (b) Comparison of PPOCT 
images with background subtraction, demonstrating the complete removal of the of noise background  
 
Using this same phantom we sought to estimate the sensitivity of the technique. 
The essential idea was to measure the signal as a function of concentration and 
extrapolate to a minimum measureable concentration. We can arrive at the appropriate 
relationship by recognizing that 𝑟L,A is measured directly by the conventional OCT signal 
and 𝛽 is a linear function of the MB concentration (𝐶). Since we only extract the sine 
modulated portion of 𝑟L the ratio of the PPOCT/OCT signals is 𝑑𝑧𝑃de𝛽 1 + 𝜔M𝜏M B* M 
where other constants not specifically considered like detector responsivity cancel 
because they are the same in both the PPOCT and OCT signals. Since all other variables 
 66 
 
are known in a phantom experiment and only 𝛽  varies with concentration, a 
measurement of this ratio as a function of concentration will reveal 𝛽(𝐶). 
Measurements were made at 5 different concentrations of MB, 0.01%, 0.5%, 1%, 
1.5% and 2%. The ratio 𝑃𝑃𝑂𝐶𝑇 𝑂𝐶𝑇𝑑𝑧𝑃de  was calculated as a function of the 
concentration and the results fit to a line to get 𝛽 𝜇𝑚B*𝑚𝑊B* = 0.087𝐶(𝑤 𝑣%) +8.7×10Br with an 𝑅M of 0.95. Based on these results, if we assume a pathlength of 15  
µm, a pump power of 1 mW, a tissue reflectivity of -30 dB, and a system sensitivty of 
110 dB we can expect to be able to measure 0.013% (41 µM) concentration of MB with 
a PPOCT SNR of 1 dB. Here we are not explicitly considering the attenuation of the 
pump beam. However, if we assume we started with the ANSI limit for skin at 660 nm 
(19 mW) at the tissue surface and assume the scattering coefficient of 10% intralipid is a 
reasonable approximation for tissue (56 cm-1 at 660 nm [152]), then the pump would be 
reduced to 1 mW of power at a depth of ~0.5 mm.  
In order to exam the capacity to measure MB in a biological sample we chose to 
image larval stage zebrafish. Zebrafish are an important model for developmental 
biology as well as numerous human diseases. [153] Larval zebrafish, treated in 
accordance with an animal use protocol overseen by the Institutional Animal Care and 
Use Committee (IACUC) at Texas A & M University, were obtained 14 days after 
breeding. The zebrafish had been treated with PTU to suppress melanin expression and 
housed in water free of MB. In order to stain the embryos a 0.01% aqueous methylene 
blue solution was prepared. The embryo was transferred to the MB solution and 
remained there for 6 hours before imaging. For reference, aquarium water is frequently 
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treated with a 10 times lower concentration of MB for its antiparasitic effect while for 
the identification of sentinel nodes [154] in breast cancer a solution about 100 times 
stronger is injected. The embryos were anesthetized with MS222 (250mg/L, tricaine) 
before imaging. For in vivo imaging the pump and probe had a power of 1.4 mW. 
In order to verify where MB was accumulating in the treated zebrafish, we 
processed histological slides were prepared for both treated and untreated specimens, 
Fig. 3a and 3b, respectively. The large dark areas on either side of the treated specimen 
near the midline correspond to the mesonephros, the basic excetory organ where MB is 
clearly accumulating in the treated sample. The mesonephros is the primodial kidney in 
fish and amphibians. MB is known to be cleared by the kidneys in humans when taken 
orally [155], so accumulation in the mesonephros was not unexpected.  It is also rapidly 
reduced to leucomethylene blue which has no visible wavelength absorption and should 
be invisible to the PPOCT technique described here. It is likely that most of the MB was 
in the reduced form during the in vivo experiments and the intense blue coloring of the 
mesonephros is due to the fact that leucomethylene blue is also rapidly oxidized to MB 
by air [38] which would have happened during processing of the slides. In the untreated 
animal there are several dark areas at the top, bottom, and sides. It seems likely that 
these are due to incomplete suppression of melanin expression.  The areas on the side 
coincide approximately to region of the mesonephros but are more superficial and likely 
due to highly pigmented stripes observed in adult zebrafish. 
Just below the histology sections in Figure 26 (c, and d) are the fused 
OCT/PPOCT cross-sectional images generated by overlaying the background removed 
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PPOCT image on top of the OCT image. The images are from a similar location, but 
different animals than the histology slides. PPOCT signal arises from the same region as 
the darkened areas in the histology slides. The size of stained region of the mesonophros 
also qualitatively agrees with the histology, showing a large stained area where the 
mesonephros should be.  The PPOCT signal along the back and superficial along the 
midline of the fish are attributed to residual melanin. 
 
 
  
Figure 26: (a),(b) Histological cross-section from a zebrafish. Treated area corresponds to 0.01% (w/v) 
MB. Large dark areas at the midline of the treated animal are interpreted as accumu- lated MB in the 
mesonephros. Other dark areas also present in the untreated animal are attributed to residual melanin. (c), 
(d) Corresponding PPOCT cross-sectional images. Note, OCT images are shown on traditional log-
intensity scale and PPOCT is shown on linear-intensity scale. (e) Intersecting planes from volumetric-data 
set with PPOCT signal and overlain on the OCT signal of a live zebrafish treated with MB.  
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4. DEVELOPMENT OF LESSLESS, ULTRA-WIDEBAND FIBER OPTIC ROTARY 
JOINT FOR BIOMEDICAL APPLICATIONS* 
 
In this chapter, the lensless and ultra-wideband fiber optic rotary joint for 
endoscopic molecular-enhanced OCT imaging is developed, and also demonstrated how 
the performance of FORJ was tested.   
4.1 Method 
 
 
Figure 27: Schematic diagram of UFORJ 
 
The primary components of the lensless ultra-wideband fiber optic rotary joint 
(UFORJ) are shown in Figure 27. A fiber chuck (FPH-J, Newport) was assembled with 
                                                
*  Reprinted with permission from [156] Kim, Wihan, Xi Chen, Javier A. Jo, and Brian E. Applegate. 
"Lensless, ultra-wideband fiber optic rotary joint for biomedical applications." Optics letters 41, no. 9 
(2016): 1973-1976.. 
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two pillow-mounted bearings and a bore diameter (∅ =3.175 mm) pulley to hold the 
rotating portion of fiber. The fiber chuck could accommodate bare fibers up to 250 µm in 
diameter. An electric motor (RE50, Maxon Motor) fitted with a bore diameter pulley 
(∅ =8 mm) was coupled to the fiber chuck via a pulley belt. The gear ratio and 
maximum rotation velocity of the loaded electric motor resulted in a maximum UFORJ 
rotational velocity of 8800 rpm. A short fiber patch cable connectorized on one side was 
placed in the fiber chuck and secured via a customized fit- ting. The connectorized end 
allows for easy substitution of fiber components on the rotating portion of the optical 
system, in our case, a fiber endoscope. The bare, cleaved, end of the patch cable was 
held by the fiber chuck and inserted into one side of a glass ferrule (FER-1.8-126-GL, 
OZ Optics) whose diameter (126 µm) was chosen to closely match the diameter of the 
bare fiber after removal of the buffer. The ferrule had conical shaped ends on both sides 
that tapered down to the inner ferrule diameter. This enabled easy damage free insertion 
of bare fiber on either end.  
The glass ferrule did not rotate and was attached to a custom fitting held in an x, 
y, z adjustment mount. The x, y, z mount allowed for careful alignment of the glass 
ferrule to the fiber chuck. The nonrotating fiber was passed through the opposite end of 
the glass ferrule and butted up against the fiber held in the fiber chuck. Both fibers were 
cleaved before being inserted into the glass ferrule. The nonrotating fiber was bonded to 
the ferrule with epoxy. The glass ferrule was filled with lubricating fluid which served 
several purposes. It reduced reflections from the cleaved fibers and provided lubrication 
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for the rotating fiber. It also enabled greater separation of the two fibers while 
maintaining good coupling efficiency.  
First, we set out to determine the suitability of potential index matching fluids to 
cover the requisite bandwidth, 355–1360 nm. In addition to being transparent over this 
range, the index matching fluid was ideally chosen to minimize insertion loss due to 
reflections from, and separation between, the two fiber end faces. Losses due to both 
sources as a function of refractive index (n) and fiber separation (Z0) have been derived 
previously [157, 158] and are given by  
   Luvw = −10 log 1 − {|B{[{|}{[ M  ,    (1) L~ = 8.686 ln 1 + *M ( /{[/[)M  ,    (2)  L	 = −10 log 1 − /M{[u| ,            (3) 
where L is the insertion loss on a dB scale due to reflection (ref), end-face separation in 
single-mode fiber (SMF), and in multi- mode fiber (MMF). Z0 is the axial separation 
between two fiber end faces, NA is the numerical aperture of the fiber, n1 is the 
refractive index of the fiber core, r is the radius of the Gaussian beam diameter in a 
multi-mode fiber, w0 is the mode field radius, and n2 is the refractive index of the 
medium inside the gap between the fibers. Plots of these three equations are provided in 
Figure 28 with the following assumptions. We assume an NA of 0.2 for a double-clad 
fiber. r is taken to be the radius of the multimode core; 52.5 µm. w0 is the mode field 
radius of the SMF core; 4.6 µm. n1 is 1.46; and n2 ranges from 1 to 2. 
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As expected, losses due to reflection [Figure 28(a)] are minimized when the 
refractive index of the lubricant (n2) matches the index of the fiber core, i.e., n1= n2. 
However, even in the worst case where the gap is air filled (n2= 1), the losses are 
relatively small at 0.15 dB. Insertion loss due to fiber end-face separation [Figure 28(b) 
and (c)] is less than 1 dB for separations in excess of 30 µm for all reasonable values of 
n2. In the case of dual-clad fiber, one could also estimate the leakage from the single to 
the multimode core by assuming that all losses go to the multimode core. Under this 
assumption, Eq. (2) and Figure 28(a) can be interpreted as the leakage. Higher n2 values 
can provide higher tolerances for fiber end-face separation, making alignment easier and 
reducing the potential for damage caused by bringing the two fibers into direct contact. 
Avoiding fiber damage by maintaining space between the two fiber end faces is expected 
to be key to achieving long operational life- times for the UFORJ. Based on these 
results, lubricants with refractive index equal to or larger than the fiber core would be 
the most desirable.  
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Figure 28: Insertion loss (a) due to reflections, (b) due to the separation of fiber end faces for single-mode 
fiber (SMF), and (c) due to sepa- ration of fiber end faces for multi-mode fiber (MMF). The fiber was 
assumed to have a refractive index of 1.46 (n1).  
 
4.2 Results 
We identified two potential lubricants both with a refractive index of 1.52. The 
first was an index matching fluid (Norland 105) with low viscosity but unknown 
absorption spectrum and UV performance. The second was microscope objective 
immersion oil (Olympus, Type-F) with relatively high viscosity and a manufacturer 
reported good performance in the UV. Using a 365 nm light source (Mos-Cure mini 365, 
U-VIX) we made a qualitative measure of the fluorescence from the two candidates. The 
immersion oil had relatively low fluorescence emission as reported by the manufacturer, 
however emission from the index matching fluid was much stronger. Based on these 
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results we moved forward with only the immersion oil since the strong fluorescence 
from the index matching fluid would introduce a strong background for fluorescence 
imaging. 
 
 
Figure 29: Images of fiber end-face damage after fiber illumination with 355 nm nanosecond laser light 
using immersion oil (Olympus, Type-F) and distilled water as lubricants (a) MMF after a few minutes 
with immersion oil, (b) DCF after a few minutes with immersion oil, (c) DCF after 20 minutes with 
immersion oil, (d) MMF after 20 minutes with water lubricant, (e) DCF after 20 mintues with water 
lubricant. 
 
We identified two potential lubricants both with a refractive index of 1.52. The 
first was an index matching fluid (Norland 105) with low viscosity but unknown 
absorption spectrum and UV performance. The second was microscope objective 
immersion oil (Olympus, Type-F) with relatively high viscosity and a manufacturer 
reported good performance in the UV. Using a 365 nm light source (Mos-Cure mini 365, 
U-VIX) we made a qualitative measure of the fluorescence from the two candidates. The 
immersion oil had relatively low fluorescence 
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Next, we tested the immersion oil in the UFORJ, filling the capillary with the oil 
before inserting the freely rotating fiber. For initial testing, we chose to assemble the 
UFORJ with a multimode fiber designed to be used with high power lasers 
(FG050UGA, Thorlabs). The fiber had a core radius of 25 µm and a NA of 0.22. The 
laser source was a 355 nm, nanosecond pulsed laser with a 10 kHz repetition rate. After 
initially achiev- ing high power throughput, the power decreased dramatically within a 
few minutes. After disassembling the UFORJ, we noted physical damage to the fiber end 
faces. To investigate further, we took bare fibers with freshly cleaved ends and coupled 
the laser source into the fiber. The laser pulse energy at the exit of the fiber was 
approximately 3 µJ at a 10 kHz repetition rate. The other end of the fiber was submerged 
in the immersion oil and illu- minated for up to 20 min. The fiber end face was then 
imaged using a fusion splicing system (Vytran, FFS-2000) that offered 0.47 µm/pixel 
sampling. Figure 29(a) shows the results for the MMF in the immersion oil after only a 
few minutes of exposure. The smooth, cleaved fiber end face is essentially completely 
re- moved with deep pitting across the entire surface of the fiber core. We postulate that 
while the fluorescence of the immersion oil is low, the absorption is sufficient to cause 
localized heating and thermal damage to the fiber. Since we were ultimately interested in 
using double-clad fiber in our application, we decided to perform similar testing with the 
SM-9/105/125-20A fiber. It has a multimode core approximately twice as big as the 
MMF, which should help mitigate the heating issue by lowering the laser intensity by a 
factor of ∼ 4. Figure 29(b) shows the results after a few minutes of exposure. There are 
some anomalies in the image, but clearly any damage is far less than with the MMF. We 
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then extended the experiment using a fresh fiber to a 20 min exposure. The results, 
Figure 29(c), show obvious damage with pronounced pitting in the fiber endface. 
Clearly, the immersion oil cannot be used as a lubricant for chronic experiments when a 
UV pulsed laser is used, e.g., fluorescence lifetime imaging. However, the immersion oil 
may be a good solution for applications that use cw laser sources, since the peak 
intensity would be drastically reduced and likely enable damage free operation.  
Since the development of our application, multimodal intra- vascular imaging 
with FLIM requires a short-pulsed UV laser source, we continued our pursuit of a 
suitable lubricant. The solution we arrived at was to simply lubricate the UFORJ with 
dis- tilled water. The solution has the requisite lack of absorption and emission over our 
desired spectral range. Likewise, with a refractive index of 1.33, it performs (see Figure 
28) fairly well in terms of minimizing insertion loss due to reflection and increasing the 
tolerance for axial alignment of the two fibers. However, it is normally not considered to 
be a good lubricant because of its low viscosity and tendency to promote oxidation. 
Neither of these concerns is particularly relevant for this application. The rotating 
surfaces in contact with water are all smooth glass surfaces and nominally not load 
bearing; hence, the relative increase in friction due to the poor lubricant will not 
significantly impact the operational lifetime of the UFORJ. As an initial test of the water 
lubricant performance, we completed similar experiments, as de- scribed above, using 
bare fibers and inspecting the fiber end face for damage. The results are in Figure 29(d) 
and (e). After 20 min of exposure, there was no observable damage to the fiber.  
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Figure 30: Measured output power variation with rotation of UFORJ. (a) Step-wise rotation through one 
cycle; (b) continuous rotation at 8800 rpm (146 Hz), 488 nm light coupled into the multimode core; and 
(c) continuous rotation at 8800 rpm (146 Hz), 1310 nm light coupled into the single-mode core.  
 
After assembling the UFORJ using the double-clad fiber and distilled water as 
the lubricant, we began testing the functional performance of the rotary joint. For testing, 
we used two lights sources, a 488 nm cw diode laser (Toptica, iBEAM-SMART- PT-
488HP) and a swept-laser source centered at 1310 nm with a sweep range of ±50 nm 
(Thorlabs, VCSEL, SL1310V1- 10048). We typically use the former for frequency 
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domain FLIM applications and the latter for optical coherence tomography. Figure 30(a) 
shows the results for both wavelengths where the 1310 (single-mode core) and 488 nm 
(multimode core) light was coupled into the double-clad fiber and the UFORJ rotated 
through 360° while measuring the output with a power meter. The peak-to-valley 
variation of the throughput power was 0.07 dB at 488 nm and 0.15 dB at 1310 nm. The 
mean and standard deviation of the output power are essentially identical for both the 
rotating and nonrotating case, i.e., within the accuracy of our measurements, there is no 
variation in the insertion loss upon rotation. We also tested the UFORJ during high-
speed rotation using fast photodetectors. Figure 30(b) and (c) show the results of 
measurements with continuous rotation at 8800 rpm (146 Hz) over 20 s. The averaged 
output power was 24 mW from 488 nm and 9.95 mW from 1310 nm with continuous 
rotation. The variation in the signal from the 488 nm laser on the photodetector, SD=7.6 
× 10−3, was similar to the noise when the laser was off, SD=6.4 × 10−3. The intensity 
noise induced by rotation in the multimode core, therefore, is less than 1%. The variation 
in the signal from the 1310 nm laser on the photodectector, SD=8.3 × 10−4, was similar 
to the noise with the laser off, SD=7.7 × 10−4. The intensity noise induced by rotation in 
the single-mode core is less than 0.1%. For both the single-mode and multimode cores, 
we are near our limits of detection; hence, the values quoted should be taken as upper 
limits.  
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Figure 31: Measured beam profile from multimode (MM) and single- mode (SM) cores of the UFORJ 
while continuously rotating at 8800 rpm and the single-mode core while fixed.  
 
Finally, we examined the integrity of the spatial mode to ensure that light 
propagating down the single-mode core was not bleeding into the multimode core at the 
interface of the two fibers. Some imaging technologies, such as OCT, suffer from 
artifacts when executed with multimode fiber. Using commercial beam profilers 
(Thorlabs, BP104-VIS or IR), we measured the profile of the fiber output after the 
UFORJ from light launched in both the single-mode and multimode cores. The 
measurements were made while rotating the UFORJ at 8800 rpm. The single-mode and 
multimode cores were illuminated with the 1310 and 488 nm light, respectively. The 
beam profiler, either Vis or IR, was placed at a fixed distance from the output of the 
fiber with no optics between. Only the relative size and shape of the two profiles have 
meaning. We expected that any significant coupling between the single-mode and 
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multimode core would appear as broadening at the base of an otherwise Gaussian 
looking profile from the single-mode core.  
Figure 31 shows the results. We first note that there is no apparent change in the 
spatial mode, comparing the fixed and rotating measurements from the single-mode. It is 
also apparent that there is no significant shoulder on the profiles from the single-mode 
core that could be attributed to 1310 nm light propagating in the multimode core. While 
there must be some leakage into the multimode core, this evidence suggests that it is 
small and beyond our current measurement technique.  
We have begun using these UFORJ initially for intravascular FLIM imaging. Our 
experience so far is that the operational lifetime of the UFORJ is at least sufficient for 
research purposes. The longest imaging session to date was 3 h with 22 pullback images 
at rotational velocities of 2400–6000 rpm. At the end of the session, the UFORJ was still 
performing well. Given that the fiber end faces need not be in direct contact, we expect 
that operational lifetimes can ultimately be made to rival those of standard commercial 
FORJ. 
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5. FREQUENCY DOMAIN PUMP-PROBE OCT LIFETIME IMAGING OF 
MICROENCAPSULATED METHYLENE BLUE QUENCHING BY OXYGEN 
 
This chapter discusses the design and development of the microencapsulated MB 
using PLGA as a new contrast agent for PPOCT and algorithms for detecting the excited 
state lifetime in the frequency domain. First subsection describes the how the 
microencapsulate MB was tested for PPOCT. Second subsection deals with how the 
microencapsulated MB works as the oxygen sensor using PPOCT. 
5.1 Method 
5.1.1 Developing microencapsulated MB and imaging it using PPOCT 
 
 
Figure 32: The solvent evaportion method. 
 
The microspheres were synthesized using a solvent evaporation method, tuned to 
yield microspheres with a diameter of 2.5 µm. In Figure 32 the process of a solvent 
evaporation method is firstly to dissolve the hydrophobic drug into an organic solvent 
containing the polymer. Secondly, the oil phase based on an organic solvent containing 
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polymer is emulsified in a water phase. Lastly the emulsified solution is centrifuged in 
order to sort the particles [159].  
The starting concentration of MB was 0.01% w/v (mg MB per 100 ml solvent). 
For reference a concentration of 1% w/v has been injected to identify sentinel lymph 
nodes in breast cancer cases. Likewise, concentrations of 0.5-1% are used in 
chromoendoscopy applications of MB.  
The PPOCT system used for this study is shown schematically in Figure 33. The 
pump source, a 663 nm diode laser, was sinusoidally modulated. The pump beam was 
directly delivered into the sample arm of the OCT system via a dichroic mirror. The 
SLD as a probe was launched into a 2x2 fused fiber coupler that formed a Michelson 
interferometer. Pump and probe beams were focused at the same position and laterally 
scanned on the sample by a galvo-scanning mirror. A tissue phantom was constructed 
from a 100 µm inside diameter plastic capillary tube containing a flowing suspension of 
MB microspheres submerged in 1% intralipid emulsion to mimic scattering in biological 
tissue. Also a tagging phantom was demonstrated by sprinkling MB microspheres onto a 
gelatin-based artificial tissue to mimic a monolayer tagging in biological tissue. The 
average probe power was 1.4 mW and the average pump power was 5.5 mW modulated 
at 10 kHz.  If there is transient absorption, the pump modulation will be transferred to 
the probe (OCT signal). The PPOCT signal is extracted by measuring an M-scan, band 
pass filtering at the modulation frequency and integrating, hence one M-scan yields a 
single PPOCT A-line. 
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Figure 33: PPOCT system. Pump source: sinusoidal modulated 663nm diode laser, Probe source:  830 nm 
center wavelength SLD, L: lens, DM: dichroic mirror, RM: refection mirror, GM: galvanometer scanner, 
OBJ: objective lens. 
 
5.1.2 Measuring the lifetime of transient absorption from the oxy/deoxygenated 
microencapsulated MB 
Using time-resolved pump-probe spectroscopy, we measured the lifetime of 
transient absorption from the microencapsulated MB. The experimental system that we 
used for pump-probe spectroscopy in Figure 34(a). Based on ground-state and transient 
absorption peaks of the aqueous MB [134], a femtosecond Ti:sapphire laser (λA =830nm, ∆λ = 	±2nm, pulse	width = 140fs, Coherent, Chamelon-Ultra II) was used as 
a probe light source and modulated with 10 kHz using a pulse picker (Coherent,). As a 
pump light source, a diode laser (λA = 663nm, ∆λ = 	±3nm, pulse	width = 400ns , 
Toptica, iBeam Smart PT660) was used and controlled by a delay generator (Highland 
Technology, P400), and 2 kHz sinusoidal signal generated from a function generator 
(Stanford Research System, DS335) was fed to modulate a pump light. By using a 
dichroic mirror (Semrock, ff670-SDi01-25×36), pump and probe beam are propagated 
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and focused onto a same focal spot of sample. The computer controlled delay generator 
externally triggered by a pulse picker was used for delaying a pump light source versus a 
probe. The pump-probe signal from two beams was measured by a bandwidth balanced 
detector (Newport, Model 2001) to suppress unwanted noise signal. In order to get pure 
transient absorption signal, an optical long pass filter (Chroma, ET810lp) was used to 
block a pump source. The procedure of data process is that the measured signal is 
Fourier-transformed along the time axis. By delaying the interpulse of probe light led by 
the pump light from 0 to 6 us, the magnitude of the Fourier-transformed data is extracted 
from the side band(12kHz) of the carrier frequency (10kHz).   
 
  
Figure 34: Time-resolved pump-probe spectroscopy system. (a) schematic diagram (a) measuring the 
lifetime of the trasient absorption from oxy/deoxygenated MB microspheres (lower-right-coner: 
controlling the oxygen level of MB microsphere by direcllty bubbling air or nitrogen gas), RM: reflective 
mirror, DM: dichroic mirror, OBJ: objective lens, LPF: low pass filter, L: focusing lens 
 
In order to oxy- or deoxygenated the MB microsphere, we directly bubbled air or 
nitrogen gas into the microencapsulated MB solution in a cuvette for an hour in Figure 
35 (b and lower-right-corner). For the reference data, 0.5% aqueous MB solution was 
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also used to measure the lifetime of transient absorption with same oxygen level by 
bubbling the gas. In order to keep the condition of oxygen level, the cuvette was well 
sealed and capped while measuring the signal. 
5.1.3 Frequency domain pump-probe OCT to measure phase shift for lifetime imaging 
A developed system and algorithm is to observe the relative phase shift between 
the pump and probe that is a reliable indicator of the oxygen concentration in the 
frequency domain. The algorithm was described previously [138]. The basic concept is 
very similar to Frequency-Domain Fluorescent Lifetime Imaging (FDFLIM) [151], 
except instead of measuring changes in fluorescence we are measuring changes in the 
transient absorption. In frequency domain, a fundamental phase limit on the phase 
distribution follows Gaussian white-noise distribution [160]. Thus, the phase sensitivity 
can be expressed with  δ∅v{ = *M×*A( |/)      (1) 
,where 𝑆𝑁𝑅 is the decible scale of PPOCT. 
In order to prove the sensitivity of the technique, we compare experimental with 
fundamental phase sensitivity. Simply we built a Fourier-domain (FD) interferometer 
that is able to shift the phase of sample signal. We measured the phase by varying τ and 
SNR. It helps to estimate the limitation of PPOCT system on measuring the phase shift 
from the microencapsulated MB with varying oxygen concentrations. 
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Figure 35: A schematic diagram of frequency-domain PPOCT (FD-PPOCT). 
 
The FD-PPOCT system is described in Figure 35. Based on PPOCT system, a 
small amount of the pump beam was reflected with a microscope cover glass and 
directed onto a few pixels at the edge of pixel array in spectrometer in order to establish 
a reference phase signal. As following same protocol to change the oxygen level of the 
MB microsphere above, the phantom was directly bubbled air or nitrogen gas into the 
MB microsphere solution. Two of each 100 µm inside diameter plastic capillary tubes 
contained a solution of oxi/deoxygenated MB microspheres. In order to maintain oxygen 
level during scanning, two ends of each capillary tube was fully sealed. The tube was 
positioned at an angle to avoid the strong specular reflection from the tube surface. 
The functional signal due to the absorption of the pump was frequency encoded by 
a 10 kHz sinusoidal modulation. The phase signal from the reference beam and the MB 
solution were then extracted at the modulation frequency from an M-scan via Fourier 
transform along the time. Because signals are shifted by the reference phase angle 
(∅vw), the measured phase (∅vuv) that we extracted from an M-scan data contains 
both the reference phase shift and the phase value (∅) of interest from MB solution 
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due to transient absorption. The actual phase should be calculated with the phase 
difference from ∅ = ∅vuv − ∅vw. 
5.2 Results 
5.2.1 Fabricating and characterizing microencapsulated MB 
 
 
Figure 36: Microencapsulated MB. (a) taken from a bright field microscope (b) taken from the SEM  
(c) absorption spectrum 
 
Figure 36(a) is a light microscope image of the fabricated microspheres loaded 
with the 0.01 % w/v MB solution. We can clearly see bluish microspheres. In Figure 
36(b), the average diameter of the bluish microspheres was ~ 2.5 um from a scanning 
electron microscope (SEM). The absorption spectrum has a peak at around 660nm that is 
similar with raw MB.  
5.2.2 Imaging microencapsulated MB using PPOCT 
Figure 37(a), (b) and (c) composite OCT/PPOCT images of the tissue phantom 
described above. The PPOCT signal was processed with the background subtraction 
method before being overlain on the gray scale OCT image. The background noise level 
was measured and averaged from above and below (±2 kHz) pump-modulation 
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frequency of PPOCT signal. The PPOCT signal at the modulation frequency is divided 
by the calculated background noise level. In order to completely remove the background 
noise signal, we set a threshold of 3 multiplied with standard deviation of background 
region on the treated PPOCT image. This algorithm was applied on each pixel in the 
PPOCT b-scan image. The algorithm is same with in vivo zebra fish experiment above 
[138]. In Figure 37(a), when the 660 nm pump laser is on, the PPOCT signal from the 
MB microsphere inside of a capillary is clearly visible in the blue-scale color image. 
While the MB microspheres were flowing within the capillary tube, the velocity was low 
enough that most of microspheres settled down to the lower half of the tube. Figure 
37(b) is the composite image with the pump radiation blocked.  
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Figure 37: PPOCT images overlaid with OCT images from MB microspheres. (a),(b) b-scan images 
(PPOCT: blue-scaled, OCT: gray-scaled), (c) volume image (PPOCT: blue-scaled, OCT: red-scaled, the 
lower-right-corner: gelatin-based artificail tissue sprilinked with MB microspheres imaged from a bright 
field microscope) 
 
We only see the OCT gray-scaled signal from the microspheres within the 
capillary tube and the intralipid emulsion. This confirms the signal is pump induced and 
essentially background free after using the background removal technique noted above. 
In Figure 37(c), the 3D volume image of OCT/PPOCT was taken from the monolayer 
phantom mentioned above. At the lower-right-corner of Figure 37, the image taken from 
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a bright field microscope shows a gelatin-based artificial tissue phantom with MB 
microspheres. The microspheres were sprinkled on the top surface of the artificial tissue 
to create the monolayer phantom that effectevely mimic the case of active tagging. The 
volume image of OCT/PPOCT clearly shows PPOCT signal on the top of the artificial 
tissue. 
 
5.2.3 Measuring the lifetime of transient absorption from microencapsulated MB 
quenching by oxygen 
 
 
Figure 38: Lifetime of the transient absorption from oxi/deoxygenated 0.5% aqueous MB and 
microencapsualted MB using time-resolved pump-probe spectroscopy 
 
By varying the oxygen concentration of the aqueous and microencapsulated MB 
with 0 or 21%, lifetime of the transient absorption was changed. Normalized lifetime 
intensity of the transient absorption is displayed in Figure 38. In case of air-bubbled, the 
lifetime of both 0.5% aqueous and rehydrated MB solution is quite same with around 1 
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us. The lifetime of deoxygenated 0.5% aqueous MB solution is about 1.8 us that is 
shorter than about 2.5 us of the deoxygenated MB microsphere. This could be happened 
by either the molecule of nitrogen could not well escape within a polymer shell or 
oxygen molecule could not penetrate into a polymer shell after deoxygenating. 
5.2.4 Measuring the theoretical phase sensitivity and shift of FD-PPOCT system 
 
 
Figure 39: Theoretical and experimental phase sensitivity of FD-PPOCT system by varying SNR 
 
We measured the experimental phase sensitivity using FD-PPOCT system. The 
algorithm to extract phase signal is similar with the PPOCT A-scan process described 
above. However, after Fourier transforming along the time domain of OCT M-scan,  the 
phase, not magnitude for PPOCT, is extracted at the modulation frequency of pump.  In 
each SNR case, the standard deviation were calculated from 30 measurements that 
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implys the system phase variation. Based on the phase sensitivity at Eq. 1, we estimated 
the theoretical phase sensitivy from the SNR of the measurements. 
 The experimental phase variations are comparably matched with theoretical 
values. As expecting, the phase sensitivity explicitly depends on the function of the 𝑆𝑁𝑅.   
5.2.5 Measuring the phase shift of microencapsulated MB quenching by oxygen 
We measured the phase differences of microencapsulated MB solution with 
different concentration of oxygen.  
 
 
Figure 40: Measured phase shift from the MB microsphere solution dissolved with two different oxygen 
levels, 21% oxygenated and 0% dioxygenated 
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A 21% oxygen concentration solution was made by bubbling atmospheric air into 
the microencapsulated MB solution. The bubbler ensured a relatively homogenous 
solution. In case of each oxygen data, the statistical values are calculated from 36 
measurments. The mean of phase angle was 0.861 with a standard deviation of 0.574. To 
get a 0% oxygen concentration, the nitogen gas was bubbed into the microencapsulated 
MB solution. Under these conditions the mean phase angle was 2.1386 with a standard 
deviation of 0.4501. Clearly the phase angle is capable of differentiating the two oxygen 
concentrations. The difference of two phases is 1.277. Based on the Eq. 1 about the 
phase sensitivity related SNR of PPCOT siganl, some sample signal having low SNR 
causes larger standard deviations.  The measured PPOCT SNR of both oxygen condition 
were 16.67 and 17.65 dB. 
We can also estimate the relative phase angle for the two oxygen concentrations 
based on the theory above and literature values for MB lifetimes under different oxygen 
conditions. Based on the theoretical equation, ϕ = tanB* ωτ , where ω is the pump 
modulation frequency and τ is the triplet state lifetime [138]. The 21% oxygen-dissolved 
solution had 1.8us lifetime [162] and phase angle was 0.112. The 0% oxygen-leveled 
solution had 79.5 us [162] lifetime and phase angle was 1.373. The difference of two 
theoretical phase is 1.261. By comparison the experimental with theoretical phase angle, 
experimental result does not match with the theoretical value because the experimental 
phase imports relative values. But the differece values are well matched. We would need 
to calirate the inherent phase lag of the system to get the absolute phase shift. In fact we 
could use this experimental phase shift to get the calibrated phase lag.  
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DISCUSSION  
 
In this dissertation, molecular contrast-enhanced imaging systems were built for 
OCT. Based on combining pump-probe spectroscopic technique, PPOCT system has 
been well researched and characterized to measure endogenous and exogenous 
molecular with morphological information. In order to extend PPOCT applications, 
UFORJ is developed for endoscopic imaging and a microencapsulate MB is developed 
for the new biocompatible contrast agent. 
Firstly, using a novel, two-color Fourier-domain PPOCT system, the first in vivo 
cross-sectional PPOCT images of Xenopus tadpole vasculature were obtained. 
Additionally, varying the interpulse delay enabled differentiation of PPOCT signals 
originating from Methylene Blue and hemoglobin. PPOCT imaging of vasculature was 
com- pared to pvOCT and DOCT and determined to more accurately demarcate tortuous 
microvasculature, while still maintaining the data needed to calculate flow information. 
Secondly, the introduction of the 663-nm diode laser, which acts as the pump in 
this implementation of pump-probe OCT (PPOCT), represents a minor modification to 
an otherwise typical OCT system. A newly developed background subtraction technique 
completely removes all background from intensity noise at the pump modulation 
frequency, simplifying the interpretation of PPOCT images. These developments have 
enabled the first in vivo imaging of MB with PPOCT that requires only minor 
modification to a standard 830-nm OCT system but enables efficient detecion of 
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methylene blue (MB). The limit of MB detection (SNR 1 dB) for a 15-µm-thick sample 
at a depth of 0.5mm, derived from phantom studies, is 41 𝜇𝑀. 
Thirdly, we have shown that a lensless fiber optic rotary joint, constructed 
by butting the ends of a fixed and rotating bare fiber, can be made to operate over 
a broad spectral range with low insertion loss. Using distilled water as the 
lubricant and index matching fluid enabled operation down into the UV, at least 
to 355 nm, and only limited by the absorption spectrum of water and chromatic 
losses in the chosen fiber. The rotary joint could also be operated at high 
rotational velocities. It was tested up to 8800 rpm. At this velocity, there is very 
little added intensity noise due to rotational misalignment and no discernable change 
in the observed spatial mode of the 1310 nm light.  
Lastly, we have developed a novel microencapsulated MB contrast agent using 
an FDA approved biocompatible polymer. The microsphere encapsulation improves the 
PPOCT signal both by enhancing the scattering and preventing the reduction of MB to 
leucomethylene blue. The surface of the microsphere can readily be functionalized to 
enable active targeting of the contrast agent without modifying the excited state 
dynamics of MB that enable PPOCT imaging. PPOCT imaging of a tissue phantom 
show strong signals from the microspheres with essentially no background.  Based on 
the success of the tissue phantom imaging we are working towards actively tagging a 
receptor for the first PPOCT imaging of an actively tagged contrast agent. By changing 
the oxygen level of a microencapsulated MB, we present preliminary experiments 
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demonstrating a frequency domain phase angle measurement of PPOCT imaging 
technique from variance oxygen-leveled MB solution. 
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SUMMARY 
 
Biological imaging techniques that are able to detect a contrast-enhanced signal 
from the target molecules have been widely applied to various techniques in the imaging 
field. The complex biological environment provides numerous and more efficient 
pathways along which the chromophores (light absorber) may release its energy. This 
energy can provide not only morphological information, but also specific molecular 
information such as a biochemical map of a sample. All diseases correlate with both 
morphological and biochemical changes.  
Optical coherence tomography (OCT) system is one of the biological imaging 
techniques.  OCT has widely been applied to many medical/clinical fields, giving benefit 
from a penetration depth of a few millimeters while maintaining a spatial resolution on 
the order of a micron [2-11]. Utilizing OCT, it is possible to selectively detect the 
ballistic propagation of backscattered light in a tissue medium. This backscattered light 
does not undergo randomized scattering or deflection to any optical beam pathway of the 
tissue. In a tissue medium, the intensity of backscattered light is varied from spatial 
variations in tissue refractive index. By measuring the variations, the sample images 
from OCT are generated.  
Unfortunately, OCT lacks the straightforward functional molecular imaging 
extensions available for other technologies, e.g. confocal fluorescence microscopy and 
fluorescence diffuse optical tomography. This is largely because incoherent processes 
such as fluorescence emission and Raman scattering are not readily detectable with low 
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coherence interferometry that is the central technique that underlies all OCT systems. 
Despite a drawback of molecular imaging with OCT, it is highly desirable to measure 
not only morphological, but also molecular information from either endogenous or 
exogenous molecules.  
In order to overcome the limitation of molecular contrast imaging for OCT, we 
propose the hybrid OCT imaging technique and a new exogenous contrast agent. Our 
contrast-enhanced imaging technique integrates OCT with a well-researched and well-
established technique: two-colored pump-probe absorption spectroscopy. Our novel 
imaging technique is called Pump-Probe OCT (PPOCT). By using PPOCT, we firstly 
imaged Hemoglobin (Hb) from direct in vivo imaging and also Methylene Blue (MB) as 
the molecular contrast agent widely applied for the clinical fields [32-37, 161]. 
Based upon current successful results, molecular imaging with OCT potentially 
gives us the ability to identify pathologies. In order to expand the capacity of PPOCT, 
we developed ultra-wideband lensless optic fiber rotary joint with excellent performance 
(<0.2 dB insertion loss with high rotational velocities up to 8800 rpm). To the best of our 
knowledge this is the first demonstration of this type of rotary joint capable of such a 
wide bandwidth and high rotational velocities. By manipulating the new contrast agent 
based on the technique by evaporating solvent with MB, we fabricated the 
microencapsulated MB as a new biocompatible contrast agent suitable for PPOCT. Also 
we have developed a FD-PPOCT system and algorithms for detecting the excited state 
lifetime in the frequency domain. We observed that the relative phase shift between the 
pump and probe is a reliable indicator of the oxygen concentration. Furthermore, these 
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results are in good agreement with our theoretical predictions. This development opens 
up the possibility of using MB for 3-D oxygen sensing with PPOCT. 
Future work for this project involves ex vivo postmortem human coronary artery 
testing of functional tagging of MB microspheres that play an important role in 
atherosclerosis and it may be possible to use this technique for retinal oxygen saturation 
measurements. 
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